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ABSTRACT
The use of antibiotics in poultry growth and disease control has led to antibiotics resistant
problem in human beings, which is a big concern among consumers. With the necessity for
judicious use of antibiotics in poultry production, alternative strategies to improve disease
resistance in poultry production are necessary. The research is more inclined towards using the
natural products available to grow healthier and antibiotic free meat animals. In the context of
exploring natural and sustainable resource of alternative to antibiotics, the biochemical milieu of
eggshell membranes (ESM) were analyzed by using mass spectrometry techniques including
matrix assisted laser desorption ionization and liquid chromatography coupled with tandem mass
spectrometry (MALDI-TOF-MS and LC-MS/MS). We found more than 300 proteins and the
abundant among them are lysozyme, ovotransferrin, ovocleidin, clusterin, ovokeratin
ovodefensin and many more. These proteins are not only antimicrobial in nature, but also many,
play a vital role in metabolic and developmental processes. A series of experimental trails were
done in which chickens by feeding ESM supplemented diet. Our initial experiments showed that
feeding 0.5% levels of eggshell membrane not only improved the body weight of chickens, but
also modulated immunoglobulin parameters and stress levels. Further experiments were done to
see the effect of ESM under endotoxin challenged conditions in which 5 week old chickens fed
with ESM supplemented or control diet were challenged with Salmonella lipopolysaccharide.
Our results showed significant difference in body weight loss, pro and anti-inflammatory genes,
and serum corticosterone levels in control versus ESM fed chickens. ESM supplemented diet not
only helped to restore the body weight loss due to LPS injection but it also helped to provides
better tolerance to endotoxin challenges as indicated by splenic cytokine profiles of the chickens.

In view of the need for alternatives to antibiotics in meat animal production, exploring the
potential of egg byproducts as nutritional modulator of immunity during post hatch period
appears logical.
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Introduction
The emergence of antibiotics resistant bacteria and their link to prophylactic use of antibiotics as
growth promoter in meat producing animals has prompted the search for alternatives to
antibiotics. Products such as probiotics, prebiotics, bacteriophages fecal extracts, yolk antibodies,
and organic acids have been used to satisfy this need. However, there is no uniformity of the
nature and the mechanisms of action of these products. Ideally, a suitable product may be that
which would not only protect animals from diseases but also not affect the growth potential and
production values of the animals. Deploying the potential of immune system to protect the
animals from disease may help. Vaccination against specific pathogens have been the examples
of such choice. However, there is no general vaccine that might provide overall resistance
against most common health problems of poultry. Besides, nonspecific immune activation is
energy expensive which can affect production values. Should it be possible to program the
immune system to protect the individual, in the concept of allostatic modulation, may be an
option. The immunity of neonates specifically, the newly hatched poultry is not completely
developed and plastic hence, it is not only vulnerable to infections but also may be trainable to
protect birds against disease without interfering with their growth and wellbeing.. Nutrition
modulation is considered one of the effective means to train the immune system and make the
animals more immunocompetent. The experiments in this dissertation examines some of these
concepts using egg shell membrane, a byproduct of poultry industry that contains a variety of
bioactive proteins and peptides, to affect immunity and health outcomes of post hatch poultry
measured through selective physiological parameters.
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The studies are divided in two parts. The first part deals with the identification of the proteins
and peptides of fresh harvested eggshell membranes (ESM) by using the mass spectrometer,
Matrix Assisted Laser Desorption Ionization Mass Spectrometry (MALDI-MS/MS), High
Pressure Liquid Chromatography (HPLC) and Liquid Chromatography-Tandem Mass
Spectrometry (LC/MS/MS) techniques. Based on the qualitative data of protein profiles of the
eggshell membranes, the biological effects of the ESM was evaluated on post hatch chickens
under both normal and endotoxin challenge conditions.
Chapter 2 discuses about the proteomic aspect of eggshell membranes and all the techniques and
procedures used to identify and characterize the protein and peptides present in eggshell
membranes by using “top down/bottom up” MALDI and ESI mass spectrometry approaches.
Chapter 3 discuses about the nutritional aspect of the eggshell membranes harvested form fresh
unfertilized eggs and their immunomodulatory effect on growth and performance of chickens at
3 weeks of age.

Chapter 4 discusses about the proteomic characterization of eggshell membranes obtained from
hatchery waste. Chapter 5 is about the ameliorating effect of eggshell membranes in conditions
of endotoxin challenge. We explored whether these membranes when give as a supplement to the
post hatch chickens can provide resistance and tolerance to the stressful conditions at a later
stage.
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Chapter 1:
Immunity and antibiotics alternative in the context of poultry health and wellbeing: a
literature review
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Introduction
Production of healthy livestock is integral to food safety, animal wellbeing, and sustainable
agriculture. The emergence of antimicrobial resistant bacteria has been a worldwide concern and
squarely blamed on the prophylactic use of antibiotics in meat animal industry where it is used as
growth promoter [1-6]. The use of antibiotics is not only implicated in producing antibiotics
resistant pathogenic bacteria but it also upsets the regular microflora [7-10]. However, the
restriction in the prophylactic use of antibiotics also increases the chance of bacterial diseases
and causes food safety problems that could potentially cripple the poultry and meat industry.
Hence, there has been increasing research focus on finding alternatives to antibiotics that would
provide resistance to microbial disease while maintaining the production values [11]. The quest
to improve immunity and disease resistance of meat producing animals and poultry thus raises
questions on options to modulate, and assess immunity This review addresses some of these
issues particularly in the context of poultry production.
Alternatives to antibiotics
The consumer’s concern and demand for antibiotic free food leads to the focus of modulation of
the avian immune system particularly using nutritional approaches which not only can increase
the production of poultry but also fulfill consumer’s demand for antibiotic free food at the same
time [12]. But the major concern in adding the alternative to antibiotics is that the product should
be equally potent to promote the growth and also keep the animal free from disease. The cost to
impact ratio on health status of an animal is another big issue that needs to be addressed when
using an alternative to antibiotics [1, 13]. Of a number of methods that have been proposed or are
on trial are vaccines, antimicrobial peptides [14-16] (exogenous or induced), bacteriophages,
probiotics[17], prebiotics, different phytochemicals (essential oils, saponins) [18] and
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recombinant cytokines (recombinant intact and/ or modified synthetically to enhance efficacy)
[13]. All these are geared to improve endogenous resistance, modulate immunity directly or
indirectly to reduce the burden of harmful agents that affect growth, wellbeing, and food security
of meat animals.
Examples of Alternatives:
Vaccines
The first and foremost method, which revolutionized the history of immunomodulation, was
vaccination discovered by Edward Jenner that has changed the face of medical research. Vaccine
is a preparation from attenuated form of a pathogen, which stimulated the immune system and
develops the memory to kill the microorganism encountered later in the life. By exposing the
immune system to a harmless form of pathogen it can be made more alert and ready for a
vigorous response in times of real pathogen attack. The biggest contribution of vaccine is
complete eradication of smallpox [19], and a significant decrease of measles, mumps and rubella
worldwide in human medicine. Vaccines can be an easy solution to many challenges faced by
poultry industry today [20]. Salmonella vaccines along with other preventative strategies are one
of the effective measures, which holds a promising future for control of food borne pathogens in
poultry products [21]. A greater success is achieved in developing coccidiosis vaccines by
injecting the chicken with Eimeria oocysts at posthatch stage [22]. Newcastle disease was
completely eradicated with the application of a Newcastle virus vaccine, which was initially
done by means of slaughtering and sanitary measures [23].
Antimicrobial proteins and peptides
Antimicrobial peptides (AMP) are endogenous or exogenous low molecular weight
proteins, which can provide protection against a wide range of microbes including bacteria, fungi
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and viruses. They are cationic in nature and create pores on the bacterial cell wall and control
microbial growth (6). AMP’s also known as “natural antibiotics” have numerous applications for
therapeutic, nutraceutical, and biotechnological industries [24]. Antimicrobial peptides specially
derived from food products are safer for human consumption. Most of them are explored mainly
in milk, egg and rice [25, 26]. Lysozymes, defensins and transferrins that are present in milk and
egg are also important molecules of our innate immune cells such as neutrophils and
macrophages [27, 28]. Lysozyme is well known for its efficacy against gram-positive bacteria
and is extensively used in food industry as natural source of food preservative, which increases
the shelf life of food [29]. Transferrins, such as lactotransferrin and ovotransferrin present in
milk and egg respectively help to fight against infections by chelating iron and thus inhibiting the
growth of bacteria by limiting the availability to this essential component needed for bacterial
growth [30]. Nissin, an antimicrobial peptide produced by lactococcus lactis, is widely used to
increase the shelf life of the food by preventing the spoilage done by pathogenic bacteria [31].
The advantage of AMP over the synthetic antibiotics is that the bacteria are less resistant to the
them as compared to the latter [24]. Advances in our understanding of the mechanism of action
of AMP’s will open up new avenues for developing novel and therapeutic applications.
Bacteriophage
A bacteriophage is a virus that lyses the bacterium, invade and kill it by disrupting its metabolic
system. Bacteriophage therapy has been reported to be an effective alternative to antibiotic in
vancomycin resistant enterococcus infection in the mouse model [32]. In contrast to antibiotics
the mode of antimicrobial action by bacteriophage does not lead to the development of resistance
mechanisms in bacteria. Because of the specific mode of action, the use of phage against the
targeted bacteria is safe for the beneficial microbiota [33]. The use of bacteriophages in the food
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industry to eliminate food born pathogens has also gained considerable recognition [34]. The
‘phage biocontrol’ approach is safe and effective at both the pre-harvest and post-harvest stage of
controlling food borne pathogens and has the potential to be considered as the most effective
methods for food safety in the future [35].
Probiotic and prebiotic
Changing of the gut microbiota through dietary means has been a subject of much discussion.
The gut biology is an important area especially in agriculture animals. The use of probiotic and
prebiotic in the treatment of various metabolic disorders is gaining momentum in past few years.
The term probiotics is defined “as a live microbial feed supplement which beneficially affects the
host animal by improving its intestinal balance” [36]. By the mechanism of competitive
exclusion, for colonization sites and the production of compounds, which are toxic for
pathogenic bacteria, probiotics inhibit bacterial growth and help to maintain the intestinal flora
[37]. Prebiotics, similarly are defined as “ a nondigestible food ingredient that beneficially affect
the host by selectively stimulating the growth and / or activity of one or limited number of
bacteria in the colon” [38]. The use of prebiotics and probiotics not only for increasing the
productivity but also for disease prevention in poultry production is deemed an effective
alternative to antibiotics to satisfy the consumer’s unmet demand of healthy and diseases free
meat. [39]
Herbal Products
The extract from various plants such as thyme, eugene, oregano have been shown to inhibit the
growth of pathogenic bacteria such as Salmonella, Escherichia coli and Clostridium in vitro as
well as in birds [40]. Essential oils (EO) extracted from different parts of the plant stimulate the
digestive tract by promoting the formation of digestive enzymes in the gut. They also exert their
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antimicrobial effect by creating the pores in the lipid bilayer of the cell membrane, which makes
the cell leaky and disturbs the metabolism of the bacteria and leads to its death [41]. The
applications of antimicrobial activity of EOs are not limited to meat and meat products but also
apply to vegetables, rice, and dairy products. However the usage of EOs can sometimes add a
flavor and distinct kind of aroma to the meat, which is a limiting factor from the consumer’s
sensory point. Due to its increasing applications in the food industry, Eos are gaining great
attention for future research, that would provide more insights into their mechanism of action
and also address safety concerns [42].
However, there is a lack of consistency regarding the findings of the effects these
additives have on the various health parameters that are measured to prove their efficacy. The
systematic investigation of the effect of additives on the various aspects of the immune system is
needed to convince the commercial producers to completely rely on these products. By keeping
in mind that the immune system is an integrated system, which cannot be determined by solely
measuring one, or few parameters will help us to avoid unintended consequences in the near
future [43, 44]. Rather than interpreting for results with individual markers if we try to
congregate the related markers together and see their mass effect, and focus on their consistency
it will help make a better conclusion [45].
Immunomodulation
Immunomodulation is the manipulation or adjustment of the immune system to improve
resistance to disease. It includes all possible means of altering the immune system such as
immunosuppression or enhancement based on the necessities of the prevailing health conditions.
Immunomodulation helps to alleviate the existing pathological condition and control the damage
done by it. In case of autoimmune problems, where the immune system attacks self-components,
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the main target is to suppress it or reduce its activity which otherwise can result in
immunopathology. In the same token, immunocompromised individuals can be susceptible to
infections and become victims of pathogenic attacks more easily, the enhancement of immunity
and protection against deadly infections [46]. Hence a well-balanced immunity against pathogen
can protect the individual against disease and improve well-being.
Nutrition immunomodulation
Well-balanced nutrition is one of the main factors which can help in optimizing the function of
the immune system [47]. Immunonutrition, even though it is an emerging science, roots back to
1880s where the effect of malnutrition was seen on the growth of lymphoid organs [48]. The
immune system and nutrition are catalogued in such a way that excess or lack of a nutrient
debilitates its function [49-51]. Excess or deficiency of essentials in the diet can make the
immune system vulnerable to several infections, which not only worsens the quality of life but
also decrease its expectancy. Even though there is a fundamental understanding of how innate
and adaptive immune systems interact for the clearance of pathogens, there is a need to
investigate further when trying to modulate the immune system to improve the quality of life.
The immune system operates under normal conditions for maintenance, but at the time of
pathogenic attack its dietary requirements change. It undergoes cell proliferation to increase the
number of leukocytes to make its army ready for the defense against the attack. There is also an
intensive demand of nutrition for the synthesis of acute phase proteins by the liver [52]. The
nutrient requirements of the immune system can also change with the type of infection an
individual encounters. By inferring the nutritional cost of the immune system it will be easy to
manipulate the essential components in the diet to manage the loss of production during infection
[52, 53]. Significant effort is made to improve immunity and disease resistance through
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nutritional means. Nutrition based epigenetic programming during the neonatal and perinatal
period may increase the efficiency of the immune system to fight against the infection [54, 55].
Nutritional immunomodulation is seen as a panacea to deal with the immune system
problems. With the dietary interventions it is possible to fine-tune the immune system and make
it better to fight with infectious agents. Since the ancient time the use of many plant products
such as green tea, turmeric, fish oil, vitamin D have proven to have a therapeutic and
ameliorating effects against sickness [56]. The idea of immunomodulation is not to overwhelm
the system by adding or deleting an ingredient in the diet but to provide a means for optimal
functioning and analyzing its consequences on the immune system. The main target of the
change in dietary elements is to see its beneficial and long lasting effects on the system, which
can make it more competent and resistant to infections.
There are several factors, which needs to be carefully considered while designing the experiment
for nutritional modulation to avoid study-to-study variation. Age, sex, genetics, eating, stress and
many more factors, which vary in different subjects, can bring inconsistency in the results [44].
Interactive factors of Immunity
Immune response is subject to endogenous control such as physiology, age, genetics and even
psychosomatic dispositions [57, 58]. Exogenous factors such as environment and nutrition can
also affect or permanently modulate the immune system, [59-61]. In the context of food animal
production the most relevant ones are genetics and nutrition although a variety of other factors
such as housing and hygiene may play roles in immune system function and in the animal’s
disposition to disease. The genetic variation influences the inflammatory response of an
individual to a given challenge. With mutations and single nucleotide polymorphism there is
greater probability of having variations in the synthesis of inflammatory mediators.
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The relationship between neural, endocrine, and immune system are still unraveled. The
neuroendocrine-immune interactions have been studied in the context of stress and inflammation
[62]. Stress activates the hypothalamic pituitary (HPA) axis affecting the release of
corticotrophin and glucocorticoids [63]. Glucocorticoids produced by adrenal gland have
profound effects on the immunological functions and the deregulation in the HPA axis greatly
affects the effector mechanism of the immune system. Stress hormones, glucocorticoids and
catecholamine influence immunity. The immunosuppressive effects of high levels of corticoids
influence the levels of cytokines produced by lymphocytes [64, 65].The nervous system and
immune system also cross talk via the HPA axis. The cytokines released by the sentinel cells in
the event of inflammation such as interleukins and TNF-a can affect neuroendocrine system and
be can be affected by it. Recent studies have also shown that the sympathetic nervous system
such as the vagus nerve that innervates the spleen is known to influence immunity [66, 67].
Under inflammatory conditions the vagus nerve stimulates the immune cells in the spleen
resulting in the production of acetylcholine that dampens the production of cytokines [68, 69].
Other evidence suggest the mutual influence of nervous and immune system and certain
neurotransmitters directly modulate the response of the cells of immune system [70]. T cells and
macrophages express β adrenergic receptors, and T cells produce acetylcholine and the
stimulation by vagus nerve also causes acetylcholine production that alters the resident immune
cell functions of spleen and liver, and their ability to produce specific cytokines [71]. The gut
harbors the second largest neural network and several neuropeptides that have been shown to
possess antimicrobial, and immunomodulatory activities, and play important roles in the
development of self-tolerance [72]. Many of these peptides produced during persistent and
chronic stress suppress the immune system and affect the outcome of a disease [73, 74].
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The immune system is relatively plastic at the time of birth and is vulnerable to infections
that can permanently alter its potential to respond to stressful situations later in life [75]. Early
life programming also known as imprinting of the immune system through the neuro-endocrine
axis have been speculated to influence immunity over the span of life [76, 77]. The enteric
endocrine and nervous system also help chemosensing of nutrients which in turn can influence
immunity [78].
The above discussions posit that allostatic modulation of immunity by way of
conditioning may be a reasonable option for programming the immune system for a balanced
response to protect against infection without the loss of productivity and wellbeing. Epigenetic
programming as a concept in physiology is not new. Susceptibility to infection are modulated by
epigenetic control of immune cells such as DNA and histone modifications [79]. Wild animals
generally show better immune responses to antigens as compared to captive animals because of
their exposure to variety of challenges from the environment [80]. In order to enhance the
chances of survival, their immune system is differently programmed since birth, thus they are
more tolerant to endotoxin challenges [81]. Perinatal malnutrition is known to have profound
neuroimmunomodulating effects in mammals to the extent that many metabolic and
inflammatory diseases develop as a result [82]. Hence a better understanding of diet and neuroimmuno interactions may help achieve the objective for restricted use of antibiotics.
Conclusion
It is apparent that the postnatal (posthatch) immune system is amenable to modulation. Immune
system not only can communicate with the brain and endocrine system, the chemicals such as
proteins and peptides produced by those systems also regulate it. The embryonic and fetal factors
exert control in training and pruning the system that is retained as immune memory to be
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expressed at the time of need. Both resistance and tolerance to microbes may be manifestations
of this memory. The programming of the immune system during posthatch period may be critical
which brings us to next set of issues such as what are the tools to accomplish such a feat? Could
it be the maternal factors such as milk in mammals or wild diets and environmental contaminants
including bacteria, viruses, and parasites that can confer broad variety of resistance and
immunity, which will benefit survival and wellbeing? Such accomplishments can be engineered
to apply to a large-scale scenario for example, poultry production where the birds need to be
competent to resist infection without sacrificing their growth potential and performance. There is
also more need for research on how do we evaluate the effect of dietary nutrients, to determine
its impact on the immune system in terms of not only evading the pathogen but also protecting
the tissue from self-destruction
Thus while making a conclusion for the modulating effect of nutrients their sustainability and
effects on the host’s susceptibility to pathogens should be considered.
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ABSTRACT
Eggshells are poultry industry byproducts with potential for use in various biological and
agricultural applications. We have been interested in the membranes underlying the calcareous
shell, as a feed supplement, which showed potential to improve immunity and performance of
post hatch poultry. Therefore, to determine their protein and peptide profiles, we extracted the
eggshell membranes (ESM) from fresh unfertilized eggs with methanol and guanidine
hydrochloride (GdHCl) to obtain soluble proteins for analysis by mass spectrometry. The
methanol extract was subjected to matrix assisted laser desorption ionization (MALDI),
electrospray ionization (ESI), high performance reverse phase liquid chromatographic separation
(HPLC) and tandem mass spectrometry (MS/MS) to determine its peptide and protein profiles.
The GdHCL extract was subjected to ESI-HPLC-MS/MS following trypsin digestion of
reduced/alkylated proteins. Nine proteins from the methanol extract and >275 proteins from the
GdHCl extract were tentatively identified. The results suggested the presence of several
abundant proteins from egg whites, such as, ovoalbumin, ovotransferrin, and lysozyme as well as
many others associated with antimicrobial, biomechanical, cytoskeletal organizational, cell
signaling, and enzyme activities. Collagens, keratin, agrin, and laminin were some of the
structural proteins present in the ESM. The methanol soluble fraction contained several clusterin
peptides and defensins particularly, 2 isoforms of gallin. The ratios of the 2 isoforms of gallin
differed between the membranes obtained from brown and white eggs. The high abundance of
several anti-microbial, immunomodulatory, and other bioactive proteins in the ESM along with
its potential to entrap various microbes and antigens may make it a suitable vehicle for oral
immunization of post hatch poultry, and improve their disease resistance.
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INTRODUCTION
With over 90 billion eggs produced annually in the USA(USDA, 2014), the egg shells constitute
a significant byproduct of the poultry industry with potential for use in various agricultural and
biomedical applications(Anton, et al., 2006; Cordeiro and Hincke, 2011; Kovacs-Nolan, et al.,
2005; Mine and Kovacs-Nolan, 2006). The egg shell consists of a calcareous outer crust
underlined by two layers of proteinaceous membranes which enclose a composite chemical
milieu of egg whites and yolk, and provide both physical and biological protection to embryo
(Ahlborn, et al., 2006; Hincke, et al., 2012). Understanding the protein and peptide constituents
of the egg shell membrane (ESM) may provide better insight into their roles in embryo
development and protection, improve egg quality, and facilitate the utilization of this agricultural
waste product. In recent years there has been many studies of the protein components of various
avian egg compartments including the ESM as well as their biological significance (Mann, et al.,
2006),(Kaweewong, et al., 2013).

However, there are very few studies of egg membrane

associated peptides. Whereas the proteins have both structural and functional bases within
tissues, the peptides also play important roles in many biological processes such as signal
transduction, transportation, and host defense(Brown and Hancock, 2006; Hu, et al., 2009;
Soloviev and Finch, 2006). Therefore, the objective of this study was to profile the extractable
peptide and protein composition of the inner eggshell membranes by using “top down/bottom
up” MALDI and ESI mass spectrometry approaches.

MATERIALS AND METHODS
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Chemicals and reagents. The following reagents and devices including Centricon YM-10
filtration units (EMDMillipore.com), C18 Nu tips (Glysci.com), 1 kDa Dispodialyzer
(Harvardapparatus.com), Spectra/Por membranes (Spectrumlabs.com), Biowide Pore C18 reverse
phase HPLC column (15 cm x 4.6 mm, 5µm particle size, 300 Å pore size, Sigma-Aldrich, St.
Louis, MO), C18 column (150 x 0.1mm, 3.5 µm particle size, 300 Å pore size, Zorbax SB
(Agilent), BCA protein assay kit, Pierce C18 spin columns, MS grade trypsin (Fisher
Scientific.com), peptide calibration standard II (m/z 500-16000, Bruker Daltonics, Bremen,
Germany), and 2-iodoacetamide (IAA) (MP Biomedicals, OH) were purchased from their
respective vendors. All other reagents and supplies including 1, 4-dithiothreitol (DTT), 2, 5dihydroxybenzoic acid (DHB), and 1,5-diaminonaphthalene (DAN), were purchased from Sigma
Aldrich (St. Louis, MO).

Egg membrane harvest and extraction. Egg shells from fresh unfertilized brown and white
eggs were washed with deionized water inside with mild scrubbing to remove loosely adsorbing
egg white proteins, and the membranes were peeled free of calcareous shells. Pooled or
individual egg shell membranes (ESM) were again washed with excess deionized water by
stirring for 2-3 h, blot dried with Whatman filter papers then chopped into small pieces for
further processing. Figure 1 shows a flow chart of the general procedure of membrane extraction
and processing. The pooled ESM were extracted by 2 methods (a) with 70% methanol containing
0.1% acetic acid in and (b) with a buffer consisting of 4 M guanidine hydrochloride (GdHCl), 20
mM EDTA, and 50 mM Na-acetate, pH 5.8. The ESM fragments were extracted by stirring with
10 volumes of respective solutions for 24 hours at 4oC. The extracts were centrifuged at 21,000
g for 15 min, and the clear supernatant dialyzed against excess 50 mM ammonium carbonate
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solution using 1,000 Da Spectra/Por membranes with 3-4 changes. The membrane retentate of
both extracts following dialysis were concentrated by lyophilization and resuspended in a smaller
volumes of 50 mM ammonium bicarbonate to measure their protein concentrations by the BCA
protein assay using bovine serum albumin (BSA) as the standard. The ESM harvested from
individual brown and white ESM were similarly extracted with acidified methanol and screened
by direct matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDITOF-MS) (Kannan, et al., 2007; Kannan, et al., 2009). The experiments were carried out in two
separate trials to confirm the overall repeatability of the results.

Direct MALDI-TOF MS of methanol extract. The methanol extracts of individual or pooled
membrane preparations were screened for their peptide profiles in the mass range of 1-20 kDa by
direct MALDI-TOF-MS using 2 dihydroxybenzoic acid (DHB) as the matrix. The standard dry
droplet method with 1:1 matrix: analyte ratio was employed to prepare spots on a Bruker ground
steel MTP 384 MALDI target plate. To find the effect of reduction and alkylation, aliquots of
samples in methanol were diluted with 3 volumes of 70% methanol containing 200 mM
ammonium bicarbonate then treated with 10 mM DTT for 10 minutes in a boiling water bath,
cooled to room temperature for 1 h followed by alkylation with 40 mM iodoacetamide for an
additional 1 h in the dark. The control samples were identically treated except that DTT was
omitted from the reaction mixture. Both control and reduced/alkylated samples were spotted on
target plates along with calibrating Bruker peptide standard II in adjacent spots. The spectra were
acquired using a Bruker Ultraflex II MALDI-TOF mass spectrometer (Bruker Daltonics GMBH,
Bremen, Germany), operated in the positive-ion reflectron mode. The ammonium bicarbonate
dialysate of the methanol extract was similarly, subjected to reduction/alkylation then dried with
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a Centrivap evaporator (Labonco) to reduce the volume, desalted, and spotted for MALDI-TOFMS. The TOF analyzer was calibrated with peptide standard II. Accurate mono isotopic peptide
masses were determined by MALDI-TOF-MS using combinations of external and internal
calibration procedures, and spotting with equal volumes of α-cyano-4-hydroxycinnamic acid
(HCCA) matrix, prepared in 0.1% FA, 50:50 water/ACN (Kannan, et al., 2013). The LIFTMS/MS was performed on selected peaks to determine their identity.

Reverse phase HPLC purification of peptides in methanol extract. The dialyzed methanol
extract was passed through a 10 kDa Centricon filter to exclude high molecular weight proteins
in order to purify some of the peaks observed in MALDI-TOF-MS. The filtrate with ≤10 kDa
peptides was evaporated with Centrivap, re-dissolved in 0.1% formic acid, centrifuged at 21,000
g, and the supernatant subjected to reverse phase HPLC purification. The chromatographic
separation was done on a BiowideC18 reverse phase column attached to an Agilent 1100 HPLC
interfaced with an ESI mass spectrometer. Several major peptide fractions based on the ESI-MS
multiply charged mass spectra corresponding to m/z 4484 and 4597, 2157, 3231, 2878, 2804,
2641, and 1902 peaks, were collected, pooled from replicate runs, and concentrated by
evaporative drying for further characterization as described below.

Peptide identification by MALDI-TOF-MS and MS/MS (LIFT-TOF/TOF). The peptide
fractions were reconstituted in smaller volumes of 50 mM ammonium bicarbonate and checked
for homogeneity by MALDI-TOF-MS then reduced and alkylated with DTT and iodoacetamide
as described above followed by trypsin digestion for 24 h at 37oC. The tryptic peptides were
desalted with C18 Nu tips, spotted on MALDI target plates with saturated HCCA as described
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above, and the spectra collected in both MALDI-TOF (MS) and LIFT-TOF/TOF (MS/MS)
modes.
MALDI-ISD (in source decay) analysis. The m/z 4597 and 4484 peptide fractions were
reconstituted in 0.1% formic acid and spotted mixed with a saturated solution of 1, 5
diaminonaphthalene (DAN) prepared in 50% ACN containing 0.1% formic acid at 1:1 ratio of
analyte: matrix then subjected to MALDI-ISD fragmentation (Fukuyama, et al., 2006; Kannan,
Liyanage, Lay Jr, Packialakshmi, Anthony and Rath, 2013; Quinton, et al., 2007). ISD spectra
were acquired with a Bruker Reflex III MALDI-TOF mass spectrometer. The MALDI-ISD mass
spectra were similarly analyzed with Bruker BioTools 3.1 to obtain sequence tags to search the
NCBI Gallus data base using protein blast. Both these peptides, m/z 4484 and 4597, were also
subjected to LIFT-TOF/TOF fragmentation for further confirmation of their identities.

Comparative differences in selective peptides of brown and white ESM. The MALDI-TOFmass spectra of methanol extracts of individual brown and white egg membranes were screened
to determine the relative spectral intensities of m/z 4597 and 4484 peptides in each preparation
and the means of the cumulative results were compared using Student’s t test.

LC-MS/MS analysis of methanol and guanidine extracted proteins.

Following the

measurement of protein concentrations of 1 kDa membrane retentate of both methanol and
GdHCl extracts as described earlier, approximately 10 µg of methanol extracted and 50 µg of
GdHCl extracted proteins were dried by vacuum evaporation and reconstituted in 10 µl of
ammonium bicarbonate, subjected to reduction and alkylation, and digestion with trypsin at a
protein: trypsin ratio of 50:1 for 24 h at 37oC. The tryptic digest was desalted using Pierce C18
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spin columns and chromatographed on a capillary C18 column (150 x 0.1mm, 3.5 µm particle
size, 300 Å pore size, Zorbax SB) attached to an Agilent 1200 series HPLC interfaced with a
Bruker Amazon-SL quadrupole ion trap mass spectrometer and captive spray ion source. Tryptic
peptides were separated at a solvent flow rate of 1.6 µL/min with 0 to 40 % gradient of 0.1% FA
(solvent A) and ACN in 0.1% FA (solvent B) over a 320 minutes period.

MALDI-TOF-MS data analysis. All MALDI-TOF-MS data were processed using Bruker Flex
Analysis 3.3 and Bruker BioTools 3.1 software. Peptides were identified using LIFT-TOF/TOF
data by searching the NCBI Gallus database using the MASCOT MS/MS ion search tool with a
peptide mass tolerance of 200 ppm and MS/MS tolerance of 0.6 Da. For MS and MS/MS data
obtained from tryptic digests of the fractions corresponding to m/z 4597, 4484, 2157, 3231,
2878, 2893, and 1902 were searched in the NCBI Gallus database as above but with trypsin,
listed as the digestion enzyme. Accurate monoisotopic peptide masses (± 0.1 Da) were used for
peptide identifications.

LC-MS/MS analyzed proteins. Peaks were picked in the LC-MS/MS chromatogram using
Bruker default settings. Bruker Proteinscape bioinformatics suite coupled with MASCOT 2.1
was used to search NCBI Gallus protein database for identification of proteins. The parent ion
mass tolerance and fragment ion mass tolerance, were both set at 0.6 Da. A MASCOT decoy
database search was performed with all the datasets. A score threshold of 45 or above was used
as a high probability match for protein identifications.

The proteins with only <1% false

discovery rate (FDR) and at least 1unique peptide were reported. Functional annotation for these
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proteins was performed using the Software Tool for Researching Annotation of Proteins
(STRAP) (Bhatia, et al., 2009).

RESULTS
MALDI-TOF-MS identification of methanol extracted proteins and peptides.

Figure 2

shows a MALDI-TOF-MS of the methanol extract of ESM shown in the range between m/z
1000-6000 range with peaks corresponding to m/z 1616, 1902, 2001, 2157, 2641, 2797, 2878,
2894, 3231, 4484, 4597, and 4778. Some of the other peaks that occurred beyond 10,000 m/z
was 14302 matching to the corresponding MW of chicken lysozyme. The methods used for
identification of some of the peaks and their identities are summarized in Table 1. The peaks
corresponding to m/z 4484, 4597, and 4778 showed a 348 Da mass difference upon reduction
and alkylation suggestive of the presence of 3 disulfide bonds while several other peaks did not
show any mass shifts (Figure 3). Reduction and alkylation, particularly under complete aqueous
conditions, rendered the m/z 4484, 4597, and some other peptides insoluble with 0.1% FA
indicated by the disappearance or observance of low intensities in MALDI signals. Figures 4
and 5 show the MALDI-ISD and MALDI-LIFT-TOF/TOF results for peptides m/z 4597 and
4484. MALDI-ISD yielded a high confident sequence tag “YCSNTCSKTQI” based on observed
c ions (N-terminus protected) from m/z 4597. MASCOT sequence query and MS/MS search
using MALDI-LIFT-TOF/TOF data and blast search against NCBI Gallus data base all, resulted
in significant hit against the protein precursor named “gallin’ with a sequence
“LVLKYCPKIGYCSNTCSKTQIWATSHGCKMYCCLPASWKW”, matching to m/z 4597.
Almost same sequence, but without the N-terminal leucine (L) is a perfect match to m/z 4484.
The peak at m/z 4778 although showed to have 3 disulfide bonds from MALDI-TOF-MS results
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(Figure 3), its identification was not possible through these means most likely due to insufficient
amounts of material. The LC-MS/MS data from the methanol extracted proteins however,
suggested a high possible identity for this peptide to be gallinacin 10 as will be described later
with LC-MS-MS results. The peaks at m/z 1902, 2001, 2157, and 3231, observed in direct
MALDI-TOF-MS, were all identified as fragments of clusterin having the common sequence tag
“TPPFGGFREAFVPPVQRVR” by MASCOT MS/MS ion search of the LIFT-TOF/TOF data
using NCBI Gallus database (Figures 6-8 and S1 and S2). The results were also supported by
bottom up identification that showed the presence of two common tryptic fragments
corresponding to their respective protonated monoisotopic masses at m/z 878.4 (TPPFGGFR)
and m/z 1042.5 (EAFVPPVQR), for each of those peptides, both derived from the same domain
of clusterin (Figures 7 and S3-S4). Thus, the m/z 1902, 2001, 2157 and 3231 peaks were
identified

as

“TPPFGGFREAFVPPVQR”,

“TPPFGGFREAFVPPVQRVR”

and

“TPPFGGFREAFVPPVQRV”,

“TPPFGGFREAFVPPVQRVRLVPPRRRLS,”

respectively (Table 1). The peptides corresponding to peaks at m/z 2878 and 2894 were both
identified by MALDI LIFT-TOF/TOF fragmentation as one phosphatase and actin regulator
protein (PHACTR) with a sequence of “PPKRGLLPTNPPEAALPSKPPGDRTVTA” and a
sporozoite

surface

protein

2-like

with

the

sequence

of

LC-MS/MS identification of methanol and GdHCl extracted peptides/proteins.

Major

“PNPIGLIGPIGPNVSNPIGLLGPNGPNAFS” (Figures 9 and 10, Table 1).

proteins identified in methanol and GdHCl extracts are listed in Table 2 and Table S1. There
were 9 proteins identified in the methanol extract and over 275 in GdHCl extract. Six of the
methanol extracted proteins were identified in the GdHCl extract which included the proteins,
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lysozyme, clusterin, gallin, and ovocleidin.

Since gallinacin 10 propeptide that contains 3

disulfide bonds (Lynn, et al., 2004), was identified in the methanol extract, we presumed that this
LC-MS/MS identified tryptic fragment “AGACPPTFTISGQCHGGLLNCCAK” could relate to
the m/z 4778 peak, observed in MALDI-TOF mass spectrum. The accurate protonated mono
isotopic mass for the m/z 4778 peak was determined to be 4772.9 ± 0.3 Da using replicate
MALDI-TOF-MS

measurements.

Combining

the

mass

information

with

the

“AGACPPTFTISGQCHGGLLNCCAK” sequence tag and MASCOT query lead to a significant
match

with

the

sequence

corresponding

“DPLFPDTVACRTQGNFCRAGACPPTFTISGQCHGGLLNCCAKIPAQ”

belonging

to
to

gallinacin 10(Lynn, Higgs, Gaines, Tierney, James, Lloyd, Fares, Mulcahy and O'Farrelly, 2004)
with a score of 308, and an expect value 8.2e-027. The sequence corresponding to the accurate
mass for m/z 4778 peptide appeared to be 5 amino acids longer N terminally than the predicted
sequence of the mature gallinacin 10 peptide(Lynn, Higgs, Gaines, Tierney, James, Lloyd, Fares,
Mulcahy and O'Farrelly, 2004; Xiao, et al., 2004).

The 2 other proteins namely, an

angiotensinogen isoform X7, and an uncharacterized protein LOC771972 isoformX1 though
were also identified from LC/MS-MS analyses of the methanol extract (Table 2) could not be
identified elsewhere.

The guanidine extract containing 276 proteins with Mascot scores 45 or above were identified
with one or more unique peptides. When the identification was done on the basis of a single
unique peptide, the fragmentation score was sufficient to identify with 95% confidence
(supplementary Table S1). GO classification done using STRAP used 103 IDs (Figure 11) to
access the likely function of the proteins based on the annotations in the database. Several high
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abundant egg white associated proteins such as ovalbumin, ovotransferrin, lysozyme,
ovomucoid, and ovoglobulin were present in ESM. A large repertoire of proteins associated with
muscle associated and motor functions such as, titin, dynein, obscurin, myosin, and nebulin, and
others with cytoskeletal organizational and anchoring functions (xin, golgin, spectrin, ninein),
enzymes (kinases, helicase, protein ligase), enzyme inhibitors (ovomucoid), and signaling
functions were identified in ESM. Proteins such as collagens, keratins, laminins, agrin, and
chondroitin sulfate that are structural components of the membrane were present in GdHCl
extract. Similarly several antimicrobial proteins such as lysozyme, gallinacin, mucin, ovocalyxin,
proteases and protease inhibitors were also identified.

Differential expression of m/z 4597 and 4484 in brown and white ESM. Figure 12 shows
comparative profiles of m/z 4484 and 4597 peaks in ESM from brown and white eggs.
Calculated by their peak intensities, the brown ESM had lower levels of m/z 4597 peptide
relative to m/z 4484 isoform of gallin than the white ESM which had higher levels of m/z 4597
and lower level of m/z 4484 peptide (brown, 0.42±0.04; white,0.72±0.08, p<0.05, n=7).

DISCUSSION
Egg is a large haploid cell and fertilized eggs can give rise to a young organism. Hence, analysis
of proteins in avian egg membrane is expected to reveal their role in nourishment, development,
immune protection and structural strength. Our results show that the eggshell membranes contain
many extractable proteins and peptides notwithstanding the fact that much of the membrane
material remains insoluble even, under chaotropic extraction condition. Many proteins identified
in the ESM have previously been shown to be present in other compartments of the egg
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(Gautron, et al., 2001; Kaweewong, Garnjanagoonchorn, Jirapakkul and Roytrakul, 2013;
Miksík, et al., 2007).

Some of these included egg white proteins such as ovalbumin,

ovotransferrin, lysozyme, clusterin, ovocleidin, ovoglycoprotein, ovomucoid, and ovoinhibitors
that are considered to be highly abundant (Boschetti and Righetti, 2008; Mann, 2007a; Rose and
Hincke, 2009). The methanol extraction led to the recovery of several peptides some of which
turned out to be the fragments of clusterin, a secretory multifunctional glycoprotein associated
with cytoprotective, and chaperon-like function(Jones and Jomary, 2002). It has been reported
that clusterin protects against a wide range of environmental, microbial, and oxidative stress
which the egg may naturally be exposed to. However, the significance of different clusterin
peptides, most of which appeared to be derived from one domain, is not understood. Two of the
peptides identified in the methanol extract by MALDI-TOF-MS were derived from, a
phosphatase and actin regulator (PHAR) protein and another, a sporozoite surface protein 2-like
protein. PHAR is involved in actin binding cytoskeletal organizing function associated with
neuronal development of embryo (Allen, et al., 2004)although the significance of its presence
along with many other signaling proteins in ESM, is not understood. However, there were also
many cytoskeletal organizational proteins identified in guanidine extracts of ESM.

The

sporozoite surface protein 2-like (SSP2-like) protein is an orthologue of a protein present on the
surface of several unicellular parasites (Tewari, et al., 2002). It is an adhesive protein that can
bind to extracellular matrix based on its function in malarial parasites (Behet, et al., 2014).
Whether SSP2-like protein acts as a decoy protein protective against parasite invasion of egg is
not known. Other major peptides of note identified in the methanol soluble fraction, were
lysozyme, a cationic, antibacterial protein which is one of the most abundant proteins present in
all compartments of the egg and 3 other defensin-like peptides corresponding to m/z 4484, 4597,
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and 4778 all of which showed to contain 3 disulfide bonds common to most avian beta defensins
(AvBD)(Lynn, Higgs, Gaines, Tierney, James, Lloyd, Fares, Mulcahy and O'Farrelly, 2004;
Zhang and Sunkara, 2014). Two of these peptides, m/z 4484 and 4597, were of interest because
they occurred at different proportions in white and brown ESM both of which were identified as
gallins with the former being shorter by a single N-terminal amino acid leucine (L). The gallin,
also known as ovodefensin, was identified by Mann(Mann, 2007b) as a meleagrin-like peptide in
chickens although similar homologous peptides were identified in many other species of
birds(Naknukool, et al., 2011; Odani, et al., 1989). Gong et al.(Gong, et al., 2010a) identified 3
isoforms of gallin in chicken oviduct suggesting the polymorphism resulted from gene
duplication. However, in ESM we detected only 2 isoforms of the same gallin in both white and
brown eggs although they occurred in differential proportions. The peptide corresponding to m/z
4778 was provisionally identified as gallinacin 10 containing 3 disulfide bonds(Lynn, et al.,
2007; Xiao, Hughes, Ando, Matsuda, Cheng, Skinner-Noble and Zhang, 2004; Zhang and
Sunkara, 2014) that we deduced to match to the stretch of sequence

corresponding to

“DPLFPDTVACRTQGNFCRAGACPPTFTISGQCHGGLLNCCAKIPAQ”.

This

nested the predicted, mature sequence of

sequence

gallinacin 10 suggesting that the m/z 4778 peptide

may be the mature peptide sequence of gallinacin 10 that is 5 amino acid longer than the
predicted sequence(Lynn, Higgs, Gaines, Tierney, James, Lloyd, Fares, Mulcahy and O'Farrelly,
2004; Xiao, Hughes, Ando, Matsuda, Cheng, Skinner-Noble and Zhang, 2004; Zhang and
Sunkara, 2014).

The occurrence of gallinacin 10 in other egg compartments and uterine

secretion have been reported(Mann, Macek and Olsen, 2006; Marie, et al., 2015).
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The GdHCl extract included most of the proteins and peptides in the methanol extract. A
functional annotation of them using the STRAP(Bhatia, Perlman, Costello and McComb, 2009),
showed these proteins being largely associated with metabolic, regulatory, developmental, and
binding activities. Collagens, keratin, laminin, agrin, ovoglycan, and chondroitin sulfate are most
likely associated with structural ecomponents of the membrane whereas proteins such as titin,
obscurin, and nebulin, that are associated with muscle biomechanical function(Meyer and
Wright, 2013), presumably, provide biomechanical support and resilience to the membrane
protecting the egg against drop damage. There were numerous cytoskeletal organizational,
anchoring, scaffolding, and tethering proteins (dynein, filamin, nesprin, ninein, xin, golgin, and
aczonin), and glycoproteins related to adhesion and differentiation functions (protocadherin),
metal and vitamin binding proteins (ovotransferrin, riboflavin-binding), enzyme proteins
(kinases, helicase, ligase), and regulatory proteins, the functional significance of which in ESM
are not understood. Many of these molecules although may have been acquired during the
passage of egg (Sun, et al., 2013) in the reproductive tract, they could very likely be responsible
for providing molecular coordination for the development of embryo.

Many proteins identified in the ESM such as defensin, ovotransferrin, ovocalyxin, and lysozyme
including some keratin peptides which have been shown to be antimicrobial conceivably provide
protection against microbial invasion (Gautron, et al., 2011; Superti, et al., 2007; Tam, et al.,
2012; Zhang and Sunkara, 2014). Protease inhibitors and anti-proteases such as ovalbumin Y,
ovomacroglobulin (ovostatin), ovomucoid, ovoglycan, also possess antimicrobial activities that
are associated with defensive functions (Gautron, et al., 2007; Huopalahti, 2007; Mann and
Mann, 2011; Mann and Mann, 2013). Mucoid substance such as ovomucin and mucin similarly,
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provide defense against virus(Lieleg, et al., 2012). 222Likewise, there are serine proteases
which possess microbiocidal activities (Heutinck, et al., 2010) present in GdHCl extracts of
ESM.

The shell membrane is an antimicrobial protein rich matrix that not only provides

protection to the egg but also harbors other proteins associated with cellular development that
can provide external cues to embryo development.

Mann et al.(Mann, et al., 2007), using decalcified egg shell membrane, identified the presence of
several phosphoproteins such as osteopontin and phosvitin which are implicated in eggshell
calcification(Hincke, et al., 2010). The conspicuous absence of these 2 proteins in the inner
eggshell membrane in our study suggests that either the shell membrane proximal to egg white,
is naturally low or deficient in these proteins since it does not undergo calcification or our search
parameters precluded the identification of these phosphoproteins. However, both ovocleidin-116
(OC-116) and ovocalyxin, both of which are phosphoproteins and implicated in mineralization
process were identified (Hincke, Nys and Gautron, 2010; Horvat-Gordon, et al., 2008) that
suggests that there was no problem related to our methodology to identify osteopontin and
phosvitin.

In conclusion, our results show that the ESM is rich in a variety of proteins and peptides many of
which are associated with different protective and supportive functions for embryo. Whereas the
presence of many abundant proteins in the ESM are consistent with the literature, the differences
in identification of some minor abundance proteins can also be attributed to other related issues
such as extraction conditions, and post translational modifications as well as search parameters
(Aebersold, 2009; Ahmed and Rice, 2005). Overall, the natural abundance of such a large
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repertoire of bioactive proteins and peptides in ESM suggests that it can be a potent nutritional
supplement to improve health and performance of post-hatch poultry(Makkar, et al., 2015b) in
the same paradigm of mammalian milk.
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Table 1: Identification of peptides or proteins corresponding to mass and the analytical methods
m/z

Sequence

Protein

1902

TPPFGGFREAFVPPVQR

clusterin

2001

TPPFGGFREAFVPPVQRV

clusterin

2157

TPPFGGFREAFVPPVQRV
R
TPPFGGFREAFVPPVQRV
RLVPPRRRLS
PPKRGLLPTNPPEAALPS
KPPGDRTVTA
PNPIGLIGPIGPNVSNPIGL
LGPNGPNAFS
VLKYCPKIGYCSNTCSKT
QIWATSHGCKMYCCLPA
SWKW
LVLKYCPKIGYCSNTCSK
TQIWATSHGCKMYCCLP
ASWKW
DPLFPDTVACRTQGNFCR
AGACPPTFTISGQCHGGL
LNCCAKIPAQ KIPAQ

clusterin

3231
2878
2894
4484
4597
4778

clusterin
phosphatase and
actin regulator
protein
sporozoite
surface
protein 2-like
gallin protein
precursor
gallin protein
precursor
predicted
gallinacin 10
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Method of
identification
MALDI LIFTTOF/TOF, PMFMS/MS
MALDI LIFTTOF/TOF, PMFMS/MS LIFTMALDI
TOF/TOF, PMFMS/MS LIFTMALDI
TOF/TOF, PMFMS/MS
MALDI-TOF-MS,
LIFT-MS-MS
MALDI-TOF-MS,
LIFT-MS-MS
MALDI-ISD,
LIFT-TOF/TOF
MALDI-ISD,
LIFT-TOF/TOF
MALDI-TOF-MS,
LC-MS/MS

Table 2. List of proteins/peptides identified from methanol extract of eggshell membrane
Accession
1 gi|345100466

2 gi|342165190
3 gi|4325105
4 gi|293321591
5 gi|212485
6 gi|513218610

7 gi|513175885

8 gi|46487955
9 gi|295982528

Protein
Chain A, Hen Egg
White Lysozyme
with A
Isoaspartate
Residue
Ovocleidin-116;
Short=OC-116;
Flags: Precursor
clusterin [Gallus
gallus]
Gallin protein
precursor [Gallus
gallus]
ovoinhibitor
[Gallus gallus]
PREDICTED:
uncharacterized
protein
LOC771972
isoformX1 [Gallus
gallus]
PREDICTED:
angiotensinogen
isoform X7
[Gallus gallus]
gallinacin 10
prepropeptide
[Gallus gallus]
Chain P, Tcr 21.30
in complex With
MHC Class II-ag
(11-27)

MW
[kDa]
14.3

Scores

#Peptides

801.6 (M:801.6)

14

76.8

285.4 (M:285.4)

7

51.3

109.6 (M:109.6)

3

4.9

90.8 (M:90.8)

2

51.9

90.6 (M:90.6)

2

27.1

71.5 (M:71.5)

2

51.3

45.3 (M:45.3)

2

7.1

35.0 (M:35.0)

1

2.0

33.4 (M:33.4)

1
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Figure 1. Flow chart of eggshell membrane (ESM) sample processing.
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Figure 2. Direct MALDI-TOF mass spectrum of 70% methanol extract of ESM spotted with
dihydroxybenzoic acid (DHB) as the MALDI matrix; m/z values of all the annotated peaks
shown between m/z 1,000-6,000 represent values closer to average masses rather than
monoisotopic masses.

Figure'2'
x1
0

4

2157

1.2

Intensity [a.u.]

1.0

4597
2894

0.8
2878

0.6

3231

0.4
1902

0.2
0.0

1079

1000

1616

1500

2837
2641
2797

4484

2001

2000

4778

2500

3000 3500
m/z

42

4000

4500

5000

Figure 3. MALDI-TOF mass spectra of methanol extract of ESM without (a) and with reduction
and alkylation with DTT/ iodoacetamide (b). Arrows show peaks that were modified by
carbamidomethylation and the m/z values of all annotated peaks represent values closer to
average masses rather than monoisotopic masses.
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Figure 4. MALDI-ISD-TOF-MS of LC purified m/z 4597 (a) and 4484 (b) peaks in Figure 2
showing the N-terminus sequence tag obtained from the corresponding c fragment ions.
MASCOT sequence query identified them as gallin precursors.
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Figure 5. MALDI LIFT-TOF/TOF fragmentation spectra for LC purified, reduced/alkylated (a)
m/z 4597 (m/z 4943) and (b) 4484 (m/z 4833) peaks showing corresponding b and y ion
fragments and their identifications gallin precursors.
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Figure 6. MALDI LIFT-TOF/TOF fragmentation for peak observed at m/z 1902 in direct
MALDI-TOF-MS shown in Figure 2. MASCOT MS/MS ion search identified it as a part of
clusterin
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Figure 7. MALDI peptide mass finger print of purified m/z 1902 in direct MALDI-TOF-MS
showing tryptic fragments m/z 878 and 1042.
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Figure 8. MALDI LIFT-TOF/TOF fragmentation of peak at m/z 2157 observed in direct
MALDI-TOF-MS in Figure 1 and MASCOT MS/MS ion search showing the corresponding
sequence ‘TPPFGGFREAFVPPVQRVR,’ identified as the clusterin fragment.
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Figure 9. MALDI LIFT-TOF/TOF fragmentation of m/z 2878 peak (Figure 2) and MASCOT
MS/MS ion search identification of as phosphatase and actin regulator protein with
corresponding fragment sequence PPKRGLLPTNPPEAALPSKPPGDRTVTA.
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Figure 10. MALDI LIFT-TOF/TOF fragmentation of peak at m/z 2894 in direct MALDI-TOFMS (Figure 2) and MASCOT MS/MS ion search showing its identification as a part of
sporozoite surface protein 2-like corresponding to the sequence
“PNPIGLIGPIGPNVSNPIGLLGPNGPNAFS”.
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Figure 11. STRAP annotation of GdHCl extracted, LC/MS/MS identified proteins
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Figure 12. Profiles of m/z 4484 and 4597 peptides expressed in white and brown ESM; the
minor peaks (arrow) are corresponding gallin isoforms with loss of H2O
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Supplementary Figure and Table legends

Figure S1. MALDI LIFT-TOF/TOF fragmentation for peak observed at m/z 2001 in direct
MALDI-TOF-MS.

!Figure!S1!
A bs. Int. * 1000
a
b
y
2.0

T
P
P
T
P
P
V
R
170.533
a2

1.4

119.566
y1

267.379
a3

100.563
b1

273.380
y2

1.2
1.0

72.568
a1

G
F

296.415
b3

1.8
1.6

F
Q

198.490
b2

G

G
V

F
F
P
P
501.190
b5
501.190
y4

442.185
b4
415.222
a4
402.258
y3

0.8

R

E

A

G

0.6
0.4

V

694.241
y6
557.314
b6
472.196
a5

529.154
a6
597.274
y5

F

A

E

R

677.214
a7

704.257
b7

V
T

G

2001.234
y 18

1559.686
y 14

1140.560
y 10

1899.749
y 17

1501.825
b 14

1060.161
b 10

1883.726
b 17

1501.825
y 13

1032.188
a 10
794.368
y7

G

1296.876
y 11

941.152
y8
832.251
a8

F

1444.775
y 12

1011.354
y9

1984.165
b 18

1277.521
a 12

960.349
a9

1953.368
a 18

0.2
0.0
250

500

750

1000

1250

m/z

53

1500

1750

2000

2250

m/z

Figure S2. MALDI LIFT-TOF/TOF fragmentation for peak observed at m/z 3231 in direct
MALDI-TOF-MS shown in Figure 2. MASCOT MS/MS ion search showed identification as a
part of clusterin with a sequence tag, TPPFGGFREAFVPPVQRVRLVPPRRRLS
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Figure S3. MALDI peptide mass finger print (PMF) of purified m/z 2001 in direct MALDI-TOFMS
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Figure S4. MALDI peptide mass finger print (PMF) of purified m/z 3231 shown by direct
MALDI-TOF-MS
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Supplement Table 1 List of proteins/peptides identified from GdHCl extract of eggshell
membrane (ESM).
MW
#Peptide
[kDa]
s
Row Accession
Protein
Scores
Gallin protein precursor
2609.0
1 gi|71274079
[Gallus gallus]
77.8
(M:2609.0)
54
Chain A, Crystal
Structure Of AluminumBound Ovotransferrin At
2.15 Angstrom
2593.4
2 gi|83754919
Resolution
75.8 (M:2593.4)
54
Chain A, Crystal
Structure Of Sovalbumin At 1.9
1698.2
Angstrom Resolution
3 gi|34811330
42.9 (M:1698.2)
34
Chain C, Crystal
Structure Of Uncleaved
1637.2
Ovalbumin At 1.95
4 gi|440923753
42.8 (M:1637.2)
32
Angstroms Resolution
ovalbumin-related
protein X [Gallus gallus
732.1
5 gi|510032768
45.4 (M:732.1)
17
gallus]
700.1
6 gi|229157
lysozyme
14.3 (M:700.1)
12
Chain A, Hen Egg White
Lysozyme With A
697.4
7 gi|345100466
Isoaspartate Residue
14.3 (M:697.4)
14
ovalbumin-related Y
595.3
8 gi|385145541
43.8 (M:595.3)
16
[Gallus gallus]
PREDICTED: titin
isoform X2 [Gallus
523.8
9 gi|513193913
gallus]
3652 (M:523.8)
34
PREDICTED: mucin-6
457.4
[Gallus gallus]
10 gi|513188927
291.1 (M:457.4)
15
443.8
11 gi|4325105
clusterin [Gallus gallus]
51.3 (M:443.8)
11
RecName:
Full=Ovalbumin-related
protein X; AltName:
405.1
12 gi|129295
Full=Gene X protein
26.3 (M:405.1)
9
ovomucoid precursor
349.6
13 gi|162952006
22.4 (M:349.6)
8
[Gallus gallus]
339.5
14 gi|223464
ovomucoid
20.2 (M:339.5)
8
PREDICTED: beta286.3
15 gi|513191195
microseminoprotein-like
12.1 (M:286.3)
6
57

[Gallus gallus]
16 gi|352173
17 gi|63052
18 gi|671865
19 gi|7441632
20 gi|385145531
21 gi|22218070

22 gi|342165190
23 gi|513167276
24 gi|212485
25 gi|513178501
26 gi|513206786

27 gi|513193378
28 gi|223059
29 gi|4204093
30 gi|363734560
31 gi|61102692
32 gi|365813307
33 gi|576329

protein,riboflavin binding
unnamed protein product
[Gallus gallus]
ovomacroglobulin,
ovostatin [Gallus gallus]
ovocleidin - chicken
ovoglobulinG2 type AB
[Gallus gallus]
ovoglycoprotein
precursor [Gallus gallus]
RecName:
Full=Ovocleidin-116;
Short=OC-116; Flags:
Precursor
PREDICTED: obscurin
[Gallus gallus]
ovoinhibitor [Gallus
gallus]
PREDICTED: dystonin
isoform X4 [Gallus
gallus]
PREDICTED:
ovoinhibitor [Gallus
gallus]
PREDICTED: dynein
heavy chain 7, axonemal
isoform X1 [Gallus
gallus]
ovalbumin N term
fragment
egg white lysozyme
[Gallus gallus]
PREDICTED: mucin-5B
isoform X1 [Gallus
gallus]
Xin [Gallus gallus]
Chain A, Crystal
Structure Of MonozBiotin-Avidin Complex
Chain A, Crystal
Structure Of Vitelline
Membrane Outer Layer
58

286.0
25 (M:286.0)
272.1
17.5 (M:272.1)
264.0
164 (M:264.0)
240.7
15.3 (M:240.7)
239.1
47.4 (M:239.1)
238.9
22.3 (M:238.9)
221.1
76.8 (M:221.1)
209.6
1158.7 (M:209.6)
148.3
51.9 (M:148.3)

6
5
8
5
9
5

8
13
4

144.0
920.1 (M:144.0)

10

137.7
57 (M:137.7)

4

133.7
458.9 (M:133.7)
130.7
4.2 (M:130.7)
124.8
4.9 (M:124.8)
122.0
233.4 (M:122.0)
116.5
216.1 (M:116.5)

9
2
4
6
8

113.3
13.6 (M:113.3)

3

112.0
18 (M:112.0)

4

34 gi|513180391
35 gi|513195515

36 gi|513206710

37 gi|513213183
38 gi|1334744
39 gi|513229885
40 gi|102221132

41 gi|513217982

42 gi|513157185
43 gi|513190030
44 gi|6433844

45 gi|513162168

Protein I (Vmo-I): A
Folding Motif With
Homologous Greek Key
Structures Related By An
Internal Three-Fold
Symmetry
PREDICTED: LOW
QUALITY PROTEIN:
transcription initiation
factor TFIID subunit 1
[Gallus gallus]
PREDICTED: nebulin
[Gallus gallus]
PREDICTED: histonelysine Nmethyltransferase, H3
lysine-36 and H4 lysine20 specific isoform X6
[Gallus gallus]
PREDICTED: golgin
subfamily A member 1
isoform X7 [Gallus
gallus]
spectrin alpha chain
[Gallus gallus]
PREDICTED: sperm
flagellar protein 2
[Gallus gallus]
apolipoprotein B [Gallus
gallus]
PREDICTED: protein
kinase C-binding protein
1 isoform X22 [Gallus
gallus]
PREDICTED: golgin
subfamily B member 1
isoform X3 [Gallus
gallus]
PREDICTED: ninein
isoform X15 [Gallus
gallus]
aczonin [Gallus gallus]
PREDICTED: uroadherence factor A
isoform X1 [Gallus
gallus]
59

109.6
216.6 (M:109.6)
107.4
752.6 (M:107.4)

107.0
290.2 (M:107.0)
106.7
90.2 (M:106.7)
105.3
281.8 (M:105.3)
103.2
270.1 (M:103.2)
102.6
523 (M:102.6)

7
8

6

6
7
7
6

101.3
132 (M:101.3)

6

100.6
362.7 (M:100.6)

6

233.4 99.6 (M:99.6)
560.4 99.2 (M:99.2)

7
6

245.5 97.2 (M:97.2)

6

46 gi|363727445

47 gi|363738135
48 gi|63370

49 gi|513217433

50 gi|513187528
51 gi|157168357
52 gi|371928996

53 gi|116669

54 gi|513218156
55 gi|293321591

56 gi|513201109

57 gi|513240592
58 gi|356991167
59 gi|513214081

PREDICTED: protein
piccolo, partial [Gallus
gallus]
PREDICTED: LOW
QUALITY PROTEIN:
chromodomain-helicaseDNA-binding protein 9
[Gallus gallus]
unnamed protein product
[Gallus gallus]
PREDICTED:
centrosome-associated
protein CEP250 isoform
X14 [Gallus gallus]
PREDICTED: spectrin
beta chain, nonerythrocytic 5 [Gallus
gallus]
centromere protein F
[Gallus gallus]
keratin 75 [Gallus gallus]
RecName: Full=AcetylCoA carboxylase;
Short=ACC; Includes:
RecName: Full=Biotin
carboxylase
PREDICTED: deathinducer obliterator 1
isoform X4 [Gallus
gallus]
Gallin protein precursor
[Gallus gallus]
PREDICTED: vacuolar
protein sorting-associated
protein 13C isoform X2
[Gallus gallus]
PREDICTED: LOW
QUALITY PROTEIN:
histone-lysine Nmethyltransferase MLL2,
partial [Gallus gallus]
E3 ubiquitin-protein
ligase HERC2 [Gallus
gallus]
PREDICTED: E3
ubiquitin-protein ligase
60

401.4 96.1 (M:96.1)

6

322.2 96.0 (M:96.0)

6

422.6 95.2 (M:95.2)

7

287.7 92.4 (M:92.4)

7

453 92.3 (M:92.3)

6

339.7 90.4 (M:90.4)
54.3 90.0 (M:90.0)

6
3

262.6 89.9 (M:89.9)

6

223.5 89.8 (M:89.8)

5

4.9 88.4 (M:88.4)

2

416.6 88.2 (M:88.2)

5

575.9 87.7 (M:87.7)

6

528.7 86.8 (M:86.8)

7

602.8 86.0 (M:86.0)

7

60 gi|513182967
61 gi|29837126

62 gi|513210403
63 gi|513189629
64 gi|392018

65 gi|363744378

66 gi|513182982
67 gi|15341204
68 gi|513193268

69 gi|513227073

70 gi|513181431
71 gi|513210496

72 gi|513182471
73 gi|513176503

RNF213 isoform X6
[Gallus gallus]
PREDICTED: rho
GTPase-activating
protein 24 isoform X5
[Gallus gallus]
SMC1 protein cohesin
subunit [Gallus gallus]
PREDICTED: LOW
QUALITY PROTEIN:
acetyl-CoA carboxylase
2 [Gallus gallus]
PREDICTED: nesprin-2
isoform X1 [Gallus
gallus]
filamin [Gallus gallus]
PREDICTED: DENN
domain-containing
protein 4C isoform X5
[Gallus gallus]
PREDICTED: rho
GTPase-activating
protein 24 isoform X10
[Gallus gallus]
cgABP260 [Gallus
gallus]
PREDICTED: A-kinase
anchor protein 9 isoform
X20 [Gallus gallus]
PREDICTED: RNA
exonuclease 1 homolog
isoform X3 [Gallus
gallus]
PREDICTED:
uncharacterized protein
KIAA1210 isoform X5
[Gallus gallus]
PREDICTED:
tetratricopeptide repeat
protein 28 [Gallus gallus]
PREDICTED:
extracellular matrix
protein FRAS1 isoform
X2 [Gallus gallus]
PREDICTED: nesprin-1
isoform X6 [Gallus
61

83.8 85.9 (M:85.9)

5

142.9 85.4 (M:85.4)

5

266.2 85.0 (M:85.0)

6

803.8 84.9 (M:84.9)
275.7 84.8 (M:84.8)

6
5

211.5 84.3 (M:84.3)

4

73.2 83.9 (M:83.9)

5

280.3 82.9 (M:82.9)

5

506.8 82.8 (M:82.8)

6

130.6 82.6 (M:82.6)

6

103.6 82.3 (M:82.3)

4

265.1 82.0 (M:82.0)

5

439.3 81.6 (M:81.6)

4

1010.5 80.6 (M:80.6)

7

74 gi|513185495

75 gi|513196869
76 gi|513176284

77 gi|513221651
78 gi|1020104
79 gi|7248371

80 gi|118090437

81 gi|513195972
82 gi|299469458
83 gi|513178510

84 gi|513202440

85 gi|91208266

gallus]
PREDICTED: Alstrom
syndrome protein 1
isoform X1 [Gallus
gallus]
PREDICTED:
nucleoprotein TPR
isoform X6 [Gallus
gallus]
PREDICTED: utrophin
isoform X2 [Gallus
gallus]
PREDICTED:
microtubule-actin crosslinking factor 1-like,
partial [Gallus gallus]
melanotransferrin/EOS47
[Gallus gallus]
myosin heavy chain
[Gallus gallus]
PREDICTED:
protocadherin Fat 1
isoform X6 [Gallus
gallus]
PREDICTED: LOW
QUALITY PROTEIN:
abnormal spindle-like
microcephaly-associated
protein homolog [Gallus
gallus]
nuclear mitotic apparatus
protein [Gallus gallus]
PREDICTED: dystonin
isoform X7 [Gallus
gallus]
PREDICTED:
microtubule-associated
protein 1A [Gallus
gallus]
RecName:
Full=Cytospin-A;
AltName: Full=SPECC1like protein; AltName:
Full=Sperm antigen with
calponin homology and
coiled-coil domains 162

292.6 79.5 (M:79.5)

5

276.8 78.7 (M:78.7)

6

351.1 78.3 (M:78.3)

5

363 78.0 (M:78.0)

6

80.9 77.9 (M:77.9)

4

223.3 76.0 (M:76.0)

5

507.9 76.0 (M:76.0)

5

398.3 75.8 (M:75.8)

6

241.4 75.8 (M:75.8)

5

308.2 75.7 (M:75.7)

5

307.1 75.5 (M:75.5)

5

124.8 75.2 (M:75.2)

5

86 gi|158186693
87 gi|363731544
88 gi|363737124

89 gi|513210175
90 gi|513179159

91 gi|513158331
92 gi|62954540

93 gi|513204692
94 gi|513183661
95 gi|478430999
96 gi|513218117

97 gi|513160180
98 gi|206597434

99 gi|50746309
100 gi|50745053

like
A-kinase anchor protein
9 [Gallus gallus]
PREDICTED: dynein
heavy chain 8, axonemal
[Gallus gallus]
PREDICTED: dedicator
of cytokinesis protein 10
[Gallus gallus]
PREDICTED:
kinetochore-associated
protein 1 isoform X3
[Gallus gallus]
PREDICTED:
intersectin-2 isoform X6
[Gallus gallus]
PREDICTED:
centrosomal protein of
290 kDa isoform X6
[Gallus gallus]
Ovocalyxin-36 precursor
[Gallus gallus]
PREDICTED: LOW
QUALITY PROTEIN:
dynein heavy chain 1,
axonemal [Gallus gallus]
PREDICTED: ankyrin-2
[Gallus gallus]
melanoma inhibitory
activity protein 3
precursor [Gallus gallus]
PREDICTED: laminin
subunit alpha-5 isoform
X9 [Gallus gallus]
PREDICTED:
ELKS/Rab6interacting/CAST family
member 1 isoform X7
[Gallus gallus]
collagen alpha-2(I) chain
precursor [Gallus gallus]
PREDICTED: rho
GTPase-activating
protein 10 isoform 2
[Gallus gallus]
PREDICTED: structural
63

455.2 75.1 (M:75.1)

5

534.2 74.6 (M:74.6)

5

249.7 74.4 (M:74.4)

3

251 73.9 (M:73.9)

4

172.2 73.7 (M:73.7)

4

288.8 73.4 (M:73.4)

5

48.8 73.2 (M:73.2)

1

489.6 73.2 (M:73.2)

5

447.9 72.8 (M:72.8)

5

221.6 72.6 (M:72.6)

5

408.8 72.3 (M:72.3)

5

117.2 72.2 (M:72.2)

5

128.8 71.9 (M:71.9)

5

88.9 71.8 (M:71.8)
127.7 70.9 (M:70.9)

5
5

101 gi|363736045

102 gi|363737706
103 gi|116248042
104 gi|513213292
105 gi|343469213

106 gi|363739068

107 gi|513180457
108 gi|513168024
109 gi|513194213

110 gi|513175708
111 gi|513190198

112 gi|363734923
113 gi|2145309
114 gi|60544838
115 gi|298542005

maintenance of
chromosomes protein 6
isoform X2 [Gallus
gallus]
PREDICTED: telomereassociated protein RIF1
[Gallus gallus]
PREDICTED: LOW
QUALITY PROTEIN:
unconventional myosinVc [Gallus gallus]
beta-defensin 11 [Gallus
gallus]
PREDICTED: myosin-3
[Gallus gallus]
MPDZ protein [Gallus
gallus]
PREDICTED: probable
phospholipidtransporting ATPase VB
isoform X8 [Gallus
gallus]
PREDICTED: testisexpressed sequence 11
protein isoform X8
[Gallus gallus]
PREDICTED: sickle tail
protein homolog isoform
X16 [Gallus gallus]
PREDICTED: bile salt
export pump isoform X2
[Gallus gallus]
PREDICTED: LOW
QUALITY PROTEIN:
ryanodine receptor 2
[Gallus gallus]
PREDICTED: protein
AHNAK2 [Gallus gallus]
PREDICTED:
cytoplasmic dynein 1
heavy chain 1 [Gallus
gallus]
TBP0 [Gallus gallus]
gonad expressed
transcript [Gallus gallus]
unnamed protein product
64

254.2 70.8 (M:70.8)

4

202.8 70.2 (M:70.2)

4

11.6 70.1 (M:70.1)

1

219 70.1 (M:70.1)

4

214.1 70.0 (M:70.0)

5

165.6 69.5 (M:69.5)

4

101.4 69.4 (M:69.4)

4

156.7 69.2 (M:69.2)

4

148.5 68.2 (M:68.2)

4

564.6 67.7 (M:67.7)

5

389.1 67.3 (M:67.3)

5

525.5 67.2 (M:67.2)
33.1 67.0 (M:67.0)

4
4

177.1 66.9 (M:66.9)
121.7 66.8 (M:66.8)

5
5

116 gi|363728442

117 gi|513164437
118 gi|21623677
119 gi|118093388
120 gi|513192568
121 gi|513188813

122 gi|513197226
123 gi|162417991
124 gi|513225858
125 gi|513208391

126 gi|513229901

127 gi|513175724

128 gi|513184797
129 gi|513204547

[Gallus gallus]
PREDICTED: coiled-coil
domain-containing
protein KIAA1407
homolog isoform X2
[Gallus gallus]
PREDICTED: ADPribosylhydrolase like 1
isoform X4 [Gallus
gallus]
SPACR [Gallus gallus]
PREDICTED: E3
ubiquitin-protein ligase
HECW2 [Gallus gallus]
PREDICTED: WD
repeat-containing protein
96 [Gallus gallus]
PREDICTED: protein
unc-79 homolog isoform
X29 [Gallus gallus]
PREDICTED:
bromodomain testisspecific protein isoform
X6 [Gallus gallus]
protocadherin Fat 3
precursor [Gallus gallus]
PREDICTED: forminlike 1 [Gallus gallus]
PREDICTED:
polycystin-1 isoform X3
[Gallus gallus]
PREDICTED: ATPdependent RNA helicase
DHX29, partial [Gallus
gallus]
PREDICTED: LOW
QUALITY PROTEIN:
lysosomal-trafficking
regulator [Gallus gallus]
PREDICTED:
biorientation of
chromosomes in cell
division 1-like isoform
X3 [Gallus gallus]
PREDICTED: stabilin-1
[Gallus gallus]
65

106 66.4 (M:66.4)

4

208.5 66.4 (M:66.4)
102.6 66.1 (M:66.1)

3
4

176 65.9 (M:65.9)

3

204 65.8 (M:65.8)

4

262.5 65.7 (M:65.7)

4

102.7 65.6 (M:65.6)

5

501.6 65.3 (M:65.3)

4

131.3 65.2 (M:65.2)

5

479.2 64.9 (M:64.9)

3

148 64.7 (M:64.7)

4

426.9 64.6 (M:64.6)

5

325.3 64.6 (M:64.6)

4

268.7 64.5 (M:64.5)

4

130 gi|513166523
131 gi|253735708

132 gi|513170156

133 gi|513160161

134 gi|363744372

135 gi|513211039

136 gi|513187516
137 gi|438007

138 gi|363732080

139 gi|513162558
140 gi|60098865

141 gi|363740639
142 gi|513181168

PREDICTED: LOW
QUALITY PROTEIN:
teneurin-4 isoform X6
[Gallus gallus]
glutathione peroxidase 3
precursor [Gallus gallus]
PREDICTED:
transcriptional repressor
NF-X1 isoform X16
[Gallus gallus]
PREDICTED:
serine/threonine-protein
kinase WNK1 isoform
X5 [Gallus gallus]
PREDICTED: LOW
QUALITY PROTEIN:
mitogen-activated protein
kinase kinase kinase 1
[Gallus gallus]
PREDICTED: DNA
polymerase epsilon
catalytic subunit A
isoform X1 [Gallus
gallus]
PREDICTED: mitogenactivated protein kinasebinding protein 1 isoform
X1 [Gallus gallus]
alpha-2-macroglobulin
receptor [Gallus gallus]
PREDICTED: BEN
domain-containing
protein 3 isoformX2
[Gallus gallus]
PREDICTED: glutamate
receptor ionotropic,
kainate 1 isoform X2
[Gallus gallus]
hypothetical protein
RCJMB04_13m2 [Gallus
gallus]
PREDICTED: myosin
heavy chain, skeletal
muscle, adult isoform X1
[Gallus gallus]
PREDICTED:
66

311.5 64.4 (M:64.4)

4

24.6 63.9 (M:63.9)

1

119.4 63.8 (M:63.8)

3

293.8 63.4 (M:63.4)

4

170.3 63.2 (M:63.2)

4

260.7 63.0 (M:63.0)

4

189.4 62.9 (M:62.9)

4

506.8 62.9 (M:62.9)

4

87.6 62.7 (M:62.7)

3

102.1 62.4 (M:62.4)

4

158.3 62.0 (M:62.0)

3

223.1 62.0 (M:62.0)
163.2 62.0 (M:62.0)

3
4

143 gi|211121
144 gi|3184528
145 gi|513162834

146 gi|363737435

147 gi|513166963

148 gi|118085134
149 gi|513165698

150 gi|513211222
151 gi|226823291

152 gi|513178325
153 gi|513228901

154 gi|513176211
155 gi|344925838

uncharacterized protein
KIAA2022 isoform X7
[Gallus gallus]
agrin [Gallus gallus]
T-Box protein 3 [Gallus
gallus]
PREDICTED: E3
ubiquitin-protein ligase
TTC3 [Gallus gallus]
PREDICTED: 1phosphatidylinositol 4,5bisphosphate
phosphodiesterase eta-1
isoform X4 [Gallus
gallus]
PREDICTED: C2
domain-containing
protein 3 isoform X6
[Gallus gallus]
PREDICTED:
cytoplasmic dynein 2
heavy chain 1 isoform
X2 [Gallus gallus]
PREDICTED: protein
furry homolog isoform
X2 [Gallus gallus]
PREDICTED: HORMA
domain-containing
protein 2 isoform X7
[Gallus gallus]
hydrocephalus inducing
homolog [Gallus gallus]
PREDICTED: LOW
QUALITY PROTEIN:
filamin-A-interacting
protein 1 [Gallus gallus]
PREDICTED: Nipped-B
homolog-like isoform X7
[Gallus gallus]
PREDICTED: mitogenactivated protein kinase
kinase kinase 4 isoform
X3 [Gallus gallus]
FYVE and coiled-coil
domain-containing
protein 1 [Gallus gallus]
67

211.3 61.9 (M:61.9)

5

46.4 61.6 (M:61.6)

4

226.8 61.2 (M:61.2)

4

188.8 61.1 (M:61.1)

5

256.9 61.0 (M:61.0)

4

491.7 61.0 (M:61.0)

3

343.8 60.9 (M:60.9)

5

38.6 60.9 (M:60.9)

3

564.4 60.6 (M:60.6)

4

137.9 60.1 (M:60.1)

4

291.1 60.1 (M:60.1)

4

178.5 59.9 (M:59.9)

4

176.8 59.9 (M:59.9)

3

156 gi|513162041
157 gi|10241574
158 gi|389616152

159 gi|513188188

160 gi|513202856

161 gi|513192909
162 gi|2463529
163 gi|513183646

164 gi|513170392

165 gi|513210289

166 gi|513229854
167 gi|513172748
168 gi|513222086

PREDICTED: pleckstrin
homology-like domain,
family B, member 2
isoform X3 [Gallus
gallus]
teneurin-2 [Gallus gallus]
TBC1 domain family
member 1 [Gallus gallus]
PREDICTED:
uncharacterized protein
LOC423333 isoform X7
[Gallus gallus]
PREDICTED: pleckstrin
homology domaincontaining family G
member 4B isoform X1
[Gallus gallus]
PREDICTED: ATPbinding cassette subfamily A member 12
[Gallus gallus]
DNA
topoisomeraseII_beta
[Gallus gallus]
PREDICTED:
protocadherin Fat 4
[Gallus gallus]
PREDICTED: lysinespecific histone
demethylase 1B isoform
X1 [Gallus gallus]
PREDICTED: LOW
QUALITY PROTEIN:
probable E3 ubiquitinprotein ligase HECTD4
[Gallus gallus]
PREDICTED:
microtubule-associated
protein 1B isoform X2
[Gallus gallus]
PREDICTED: oxygenregulated protein 1
[Gallus gallus]
PREDICTED: suppressor
of tumorigenicity 14
protein homolog isoform
68

147.7 59.8 (M:59.8)
310.6 59.8 (M:59.8)

4
4

134.2 59.8 (M:59.8)

3

193.9 59.7 (M:59.7)

4

125.1 59.6 (M:59.6)

4

428.2 59.6 (M:59.6)

5

183.1 59.5 (M:59.5)

4

543.7 59.4 (M:59.4)

4

65.9 59.1 (M:59.1)

4

486.2 59.1 (M:59.1)

3

288.8 58.7 (M:58.7)

4

390.1 58.6 (M:58.6)

4

94.1 58.4 (M:58.4)

4

169 gi|513209631

170 gi|513169783

171 gi|14278285
172 gi|50733622

173 gi|513178813

174 gi|513199927
175 gi|50593343

176 gi|513175430
177 gi|313661353

178 gi|363734028

179 gi|462740

X16 [Gallus gallus]
PREDICTED: dynein
heavy chain 3, axonemal
isoform X11 [Gallus
gallus]
PREDICTED: LOW
QUALITY PROTEIN:
golgin subfamily A
member 4 [Gallus gallus]
Chain A, Crystal
Structure Of Avian Atic,
A Bifunctional
Transformylase And
Cyclohydrolase Enzyme
In Purine Biosynthesis At
1.75 Ang. Resolution
PREDICTED: CD83
antigen [Gallus gallus]
PREDICTED: myelin
transcription factor 1-like
isoform X30 [Gallus
gallus]
PREDICTED: leucinerich repeat-containing
protein 31 isoform X2
[Gallus gallus]
axin protein 1 transcript
variant 1 [Gallus gallus]
PREDICTED:
baculoviral IAP repeatcontaining protein 6
[Gallus gallus]
rho-associated protein
kinase 1 [Gallus gallus]
PREDICTED: LOW
QUALITY PROTEIN: 1phosphatidylinositol 4,5bisphosphate
phosphodiesterase beta-2
[Gallus gallus]
RecName:
Full=Neuronal cell
adhesion molecule;
Short=Nr-CAM;
AltName: Full=Neuronal
surface protein Bravo;
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432.9 58.1 (M:58.1)

4

264.1 57.5 (M:57.5)

3

64.2 57.3 (M:57.3)

4

23.6 57.2 (M:57.2)

3

111 57.0 (M:57.0)

4

64.1 56.8 (M:56.8)

3

94.8 56.5 (M:56.5)

2

506.2 56.4 (M:56.4)

3

158.6 56.4 (M:56.4)

4

138.5 56.4 (M:56.4)

4

141.8 56.2 (M:56.2)

3

180 gi|513182151

181 gi|513187539

182 gi|513158072
183 gi|227016

184 gi|513229146

185 gi|513163146
186 gi|510936992

187 gi|513199109
188 gi|117380068

189 gi|513188106
190 gi|513174643

Short=gBravo; AltName:
Full=NgCAM-related
cell adhesion molecule;
Short=Ng-CAM-related;
Flags: Precursor
PREDICTED: SWI/SNFrelated matrix-associated
actin-dependent regulator
of chromatin subfamily
A member 5 isoform X1
[Gallus gallus]
PREDICTED: cytosolic
phospholipase A2 epsilon
isoform X2 [Gallus
gallus]
PREDICTED: LOW
QUALITY PROTEIN:
gamma-tubulin complex
component 6 [Gallus
gallus]
apolipoprotein AI
PREDICTED:
chondroitin sulfate
proteoglycan 4-like
isoform X2 [Gallus
gallus]
PREDICTED: peripheral
plasma membrane
protein CASK isoform
X11 [Gallus gallus]
chromodomain-helicaseDNA-binding protein 2
[Gallus gallus]
PREDICTED: kinesin
family member 1A
isoform X5 [Gallus
gallus]
cortactin-binding protein
2 [Gallus gallus]
PREDICTED:
bromodomain adjacent to
zinc finger domain
protein 1A isoform X7
[Gallus gallus]
PREDICTED: nineinlike protein isoform X10

70

116.6 56.0 (M:56.0)

4

91.7 55.9 (M:55.9)

3

203.3 55.8 (M:55.8)
28.8 55.7 (M:55.7)

4
3

275.9 55.6 (M:55.6)

3

94.5 55.3 (M:55.3)

3

212.7 54.9 (M:54.9)

4

192.4 54.4 (M:54.4)

4

177.9 54.4 (M:54.4)

3

168.3 54.3 (M:54.3)

3

62.8 54.1 (M:54.1)

4

191 gi|513193788
192 gi|53130528

193 gi|513172897
194 gi|513158188
195 gi|76468580

196 gi|118095631

197 gi|513200951
198 gi|513166677

199 gi|513194247
200 gi|14017756

201 gi|513181916

202 gi|513209317
203 gi|513158974

[Gallus gallus]
PREDICTED:
neurobeachin-like 1
isoform X12 [Gallus
gallus]
hypothetical protein
RCJMB04_8i12 [Gallus
gallus]
PREDICTED: LOW
QUALITY PROTEIN:
regulating synaptic
membrane exocytosis
protein 2 [Gallus gallus]
PREDICTED: DNA
helicase B isoform X3
[Gallus gallus]
aldehyde oxidase 2
[Gallus gallus]
PREDICTED: probable
E3 ubiquitin-protein
ligase HERC1 isoform
X8 [Gallus gallus]
PREDICTED: S phase
cyclin A-associated
protein in the
endoplasmic reticulum
isoform X6 [Gallus
gallus]
PREDICTED: atherinlike [Gallus gallus]
PREDICTED: lowdensity lipoprotein
receptor-related protein 2
isoform X9 [Gallus
gallus]
chick atrial myosin heavy
chain [Gallus gallus]
PREDICTED: probable
ATP-dependent RNA
helicase DDX60 isoform
X1 [Gallus gallus]
PREDICTED:
tetratricopeptide repeat
protein 18 isoform X1
[Gallus gallus]
PREDICTED:
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306.2 54.0 (M:54.0)

3

109.8 53.9 (M:53.9)

3

181.8 53.8 (M:53.8)

3

116.1 53.7 (M:53.7)

2

147.7 53.6 (M:53.6)

4

532.6 53.0 (M:53.0)

4

154.5 52.8 (M:52.8)

3

33.5 52.7 (M:52.7)

2

521.8 52.5 (M:52.5)

4

221.7 52.3 (M:52.3)

3

210.8 51.9 (M:51.9)

4

138.2 51.8 (M:51.8)
207 51.6 (M:51.6)

3
3

204 gi|513185632

205 gi|513232435
206 gi|513203915
207 gi|53133498

208 gi|513165204

209 gi|513163290
210 gi|513212577
211 gi|483968268

212 gi|513211075
213 gi|363731756
214 gi|513171368
215 gi|513178065
216 gi|513209920

transcription factor 20
isoform X7 [Gallus
gallus]
PREDICTED: attractin,
partial [Gallus gallus]
PREDICTED:
proteasome-associated
protein ECM29 homolog
isoform X3 [Gallus
gallus]
PREDICTED: polycystic
kidney disease protein 1like 2 [Gallus gallus]
hypothetical protein
RCJMB04_17e23
[Gallus gallus]
PREDICTED: von
Willebrand factor A
domain-containing
protein 8-like [Gallus
gallus]
PREDICTED: maestro
heat-like repeatcontaining protein family
member 2B-like isoform
X9 [Gallus gallus]
PREDICTED: protein
PRRC2B isoform X15
[Gallus gallus]
mRNA turnover protein
4 homolog [Gallus
gallus]
PREDICTED: scavenger
receptor class F member
2 isoform X2 [Gallus
gallus]
PREDICTED: usherin
[Gallus gallus]
PREDICTED: dynein
heavy chain 5, axonemallike [Gallus gallus]
PREDICTED: midasin
isoform X4 [Gallus
gallus]
PREDICTED: probable
ATP-dependent RNA
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144.3 51.5 (M:51.5)

3

203.9 51.4 (M:51.4)

4

273.3 51.4 (M:51.4)

4

49.4 51.4 (M:51.4)

3

213.4 51.3 (M:51.3)

3

141.2 51.2 (M:51.2)

3

245.8 51.1 (M:51.1)

4

28 50.8 (M:50.8)

3

102.3 50.7 (M:50.7)

3

573.9 50.7 (M:50.7)

3

533.7 50.7 (M:50.7)

4

632.3 50.4 (M:50.4)

3

116.8 50.4 (M:50.4)

3

217 gi|513221021

218 gi|513194426
219 gi|53133818
220 gi|211622

221 gi|513200349
222 gi|293651608
223 gi|5733818
224 gi|2330003

225 gi|513211995

226 gi|513191098
227 gi|363728726

228 gi|118102546
229 gi|50582493
230 gi|513175768

helicase DHX37 isoform
X3 [Gallus gallus]
PREDICTED: lysinespecific histone
demethylase 1A, partial
[Gallus gallus]
PREDICTED:
tetratricopeptide repeat
protein 21B isoform X3
[Gallus gallus]
hypothetical protein
RCJMB04_20k2 [Gallus
gallus]
alpha-3 collagen type VI
[Gallus gallus]
PREDICTED: mediator
complex subunit 12-like
isoform X3 [Gallus
gallus]
cytoplasmic linker
associated protein 2
[Gallus gallus]
gephyrin [Gallus gallus]
glutamine rich protein,
partial [Gallus gallus]
PREDICTED: FK506binding protein 15
isoform X8 [Gallus
gallus]
PREDICTED: golgispecific brefeldin Aresistance guanine
nucleotide exchange
factor 1 isoform X5
[Gallus gallus]
PREDICTED: protein
dopey-2 [Gallus gallus]
PREDICTED: inositol
1,4,5-trisphosphate
receptor type 3 isoform
X2 [Gallus gallus]
vitellogenin [Gallus
gallus]
PREDICTED: AT-rich
interactive domaincontaining protein 4B
73

86.3 50.3 (M:50.3)

3

157.3 50.2 (M:50.2)

3

86.2 50.2 (M:50.2)

3

339.4 50.0 (M:50.0)

3

237.8 49.6 (M:49.6)

3

164.8 49.5 (M:49.5)
79.7 49.5 (M:49.5)

3
3

112.2 49.5 (M:49.5)

4

138.3 49.4 (M:49.4)

4

200.2 49.4 (M:49.4)

3

257.7 49.3 (M:49.3)

2

304.6 49.3 (M:49.3)

4

162.5 49.3 (M:49.3)

3

146.3 49.2 (M:49.2)

3

231 gi|513224576

232 gi|20140635

233 gi|363738939

234 gi|513171922
235 gi|146219852
236 gi|53136870

237 gi|513223426
238 gi|513179755

239 gi|513190759

240 gi|513184258

241 gi|363735853

isoform X2 [Gallus
gallus]
PREDICTED: pleckstrin
homology domaincontaining family A
member 6 isoform X27
[Gallus gallus]
RecName:
Full=Transferrin receptor
protein 1; Short=TR;
Short=TfR; Short=TfR1;
Short=Trfr
PREDICTED: SH3 and
PX domain-containing
protein 2B isoform X3
[Gallus gallus]
PREDICTED: growth
regulation by estrogen in
breast cancer-like
isoform X13 [Gallus
gallus]
breast cancer 2, early
onset [Gallus gallus]
hypothetical protein
RCJMB04_35e7 [Gallus
gallus]
PREDICTED:
nucleoporin 210kDa-like
isoform X7 [Gallus
gallus]
PREDICTED: tudor
domain-containing
protein 6 [Gallus gallus]
PREDICTED: activating
signal cointegrator 1
complex subunit 1
isoform X7 [Gallus
gallus]
PREDICTED: NF-X1type zinc finger protein
NFXL1 isoform X3
[Gallus gallus]
PREDICTED:
alkyldihydroxyacetoneph
osphate synthase,
peroxisomal [Gallus

74

114.2 49.2 (M:49.2)

3

85.6 49.0 (M:49.0)

4

96.4 48.8 (M:48.8)

3

194.6 48.7 (M:48.7)

3

377.5 48.7 (M:48.7)

3

94.1 48.5 (M:48.5)

3

188.4 48.5 (M:48.5)

2

172.7 48.4 (M:48.4)

4

40.8 48.1 (M:48.1)

3

84.4 47.9 (M:47.9)

4

70.7 47.8 (M:47.8)

3

242 gi|513232874
243 gi|186703014

244 gi|513239041
245 gi|60099181

246 gi|513178375

247 gi|363733842
248 gi|313747559

249 gi|513229372

250 gi|513200909
251 gi|513229093

252 gi|513164384
253 gi|241982727
254 gi|513221255

gallus]
PREDICTED: Dmx-like
1 isoform X4 [Gallus
gallus]
PNPLA7 [Gallus gallus]
PREDICTED: maestro
heat-like repeatcontaining protein family
member 2B-like isoform
X5 [Gallus gallus]
hypothetical protein
RCJMB04_32g20
[Gallus gallus]
PREDICTED: regulating
synaptic membrane
exocytosis protein 1
isoform X12 [Gallus
gallus]
PREDICTED: LOW
QUALITY PROTEIN:
regulator of G-protein
signaling 12 [Gallus
gallus]
A-kinase anchor protein
8-like [Gallus gallus]
PREDICTED: A
disintegrin and
metalloproteinase with
thrombospondin motifs 6
isoform X10 [Gallus
gallus]
PREDICTED:
chondroitin sulfate
proteoglycan 4 isoform
X5 [Gallus gallus]
PREDICTED: integrin
alpha-2 [Gallus gallus]
PREDICTED: LOW
QUALITY PROTEIN:
E3 SUMO-protein ligase
RanBP2 [Gallus gallus]
protein ELYS [Gallus
gallus]
PREDICTED: splicing
factor, proline- and
glutamine-rich isoform
75

272.6 47.8 (M:47.8)
147.6 47.7 (M:47.7)

3
3

128.8 47.6 (M:47.6)

3

138 47.5 (M:47.5)

3

174 47.4 (M:47.4)

3

166.4 47.4 (M:47.4)

4

80.4 47.1 (M:47.1)

4

109.6 47.1 (M:47.1)

3

266.8 47.0 (M:47.0)

3

129.6 47.0 (M:47.0)

3

336.3 46.9 (M:46.9)

3

252.5 46.8 (M:46.8)

3

68.7 46.7 (M:46.7)

3

255 gi|513176328
256 gi|313851036

257 gi|513191260
258 gi|60098943

259 gi|50742516
260 gi|349732129

261 gi|513200221
262 gi|534285973
263 gi|53129447
264 gi|513225769
265 gi|118082738

266 gi|513226968

267 gi|513163173
268 gi|363727703

X6 [Gallus gallus]
PREDICTED:
androglobin [Gallus
gallus]
cytoskeleton-associated
protein 5 [Gallus gallus]
PREDICTED: LOW
QUALITY PROTEIN:
WD repeat- and FYVE
domain-containing
protein 4 [Gallus gallus]
hypothetical protein
RCJMB04_16d21
[Gallus gallus]
PREDICTED: TGF-betaactivated kinase 1 and
MAP3K7-binding
protein 2 isoform X2
[Gallus gallus]
rho GTPase-activating
protein 29 [Gallus gallus]
PREDICTED: leucine-,
glutamate- and lysinerich protein 1 isoform
X21 [Gallus gallus]
Chain A, Crystal
Structure Of Chicken
Galectin 2
hypothetical protein
RCJMB04_5l15 [Gallus
gallus]
PREDICTED: protein
TANC2 isoform X19
[Gallus gallus]
PREDICTED: nucleolar
protein 12 [Gallus gallus]
PREDICTED: tRNAdihydrouridine(47)
synthase [NAD(P)(+)]like [Gallus gallus]
PREDICTED: probable
ubiquitin carboxylterminal hydrolase FAFX isoform X3 [Gallus
gallus]
PREDICTED: apoptotic
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182.1 46.6 (M:46.6)

3

225.2 46.6 (M:46.6)

3

357.7 46.5 (M:46.5)

3

88.6 46.4 (M:46.4)

3

76.7 46.4 (M:46.4)

3

151.7 46.2 (M:46.2)

3

77.7 46.2 (M:46.2)

3

14.9 46.2 (M:46.2)

3

86.5 46.0 (M:46.0)

3

205.4 46.0 (M:46.0)

3

24.9 45.9 (M:45.9)

2

89.5 45.9 (M:45.9)

2

289.5 45.8 (M:45.8)
142.2 45.8 (M:45.8)

2
2

269 gi|513192043

270 gi|363733636

271 gi|513200631

272 gi|513171872

273 gi|513199614

274 gi|513163748
275 gi|1096715

276 gi|513192529

protease-activating factor
1 isoformX4 [Gallus
gallus]
PREDICTED: von
Willebrand factor A
domain-containing
protein 2 isoform X4
[Gallus gallus]
PREDICTED: LOW
QUALITY PROTEIN:
DNA-directed RNA
polymerase I subunit
RPA1 [Gallus gallus]
PREDICTED: LOW
QUALITY PROTEIN:
unconventional myosinIXa [Gallus gallus]
PREDICTED: LOW
QUALITY PROTEIN:
erythrocyte membrane
protein band 4.1-like 3
[Gallus gallus]
PREDICTED: DIS3
mitotic control homolog
(S. cerevisiae)-like 2
isoform X2 [Gallus
gallus]
PREDICTED: FERM
and PDZ domaincontaining protein 4
isoform X3 [Gallus
gallus]
DNA methyltransferase
PREDICTED: LOW
QUALITY PROTEIN:
kinesin-like protein
KIF20B [Gallus gallus]
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76.8 45.7 (M:45.7)

3

192.5 45.5 (M:45.5)

3

301.4 45.5 (M:45.5)

3

158.4 45.5 (M:45.5)

2

126.4 45.3 (M:45.3)

3

194.3 45.3 (M:45.3)
172.8 45.2 (M:45.2)

3
3

207 45.1 (M:45.1)

2
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ABSTRACT
Eggshell membranes (ESM) contain a variety of proteins and peptides which help in the
development of embryo and provide protection to it. Many of the peptides and proteins
associated with ESM have antimicrobial, immune-modulatory, and adjuvant properties. We
hypothesized that the membrane byproducts from egg, provided as post hatch nutritional
supplements to chickens, may improve their performance and immunity. To explore its effect,
we fed 3 groups of broiler chicks with feed containing 0, 0.2% and 0.4% ESM from day 1 post
hatch through 14 days and regular feed thereafter. The birds were individually weighed at the
onset of the experiment and at weekly intervals until the termination at third week when they
were bled and euthanized. The relative weights of liver, spleen, bursa, and heart, hematology
profiles, clinical chemistry variables including serum IgM, IgG and corticosterone concentrations
measured. The chickens in the ESM treated groups showed a statistically significant increase in
BW with no impact on relative organ weights. Compared with controls, the WBC and
lymphocyte percentage increased in chickens fed 0.4% ESM whereas the monocyte percentage
decreased at both levels of ESM. Except for the serum protein which increased in ESM fed birds
no other metabolic clinical chemistry variables showed any significant change. Both IgM and
IgG(Y) levels were elevated and corticosterone levels reduced in chickens fed ESM
supplemented diets. Our results suggest that ESM supplements during the early phases of growth
may improve immunity and stress variables, and enhance their growth performance without any
detrimental effect on other physiological parameters.
Key words: egg shell membrane, chicken, growth, immunity, stress
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INTRODUCTION
Eggshells are byproducts of the poultry industry, which consist largely of calcareous outer shells
underlined by proteinaceous membranes and the proteins that adsorb to these membranes from
egg white (Hincke, et al., 2012; Mann, 2007; Mine and Kovacs-Nolan, 2006). The shell
membranes (ESM) are fibrous structural proteins made up of collagens and keratins that are
generally resistant to conventional gastric proteases. However there are also numerous other
proteins and peptides with antimicrobial, antioxidant, and immune-modulatory properties such as
lysozyme, ovotransferrin, ovalbumin, globulins, ovomucins, and defensins present in these
membranes (Miksík, et al., 2007). Many of these proteins are functionally similar to some milk
proteins which confer post-natal protection to newborns, help maturation of gut, and shape their
microbiome (Lawrence and Pane, 2007; Rose and Hincke, 2009). Antimicrobial peptides not
only provide protection against a wide range of microbes including bacteria and fungi but also
can function as adjuvants enhancing immunity against foreign antigens (Brown and Hancock,
2006). In view of the need for alternatives to antibiotics in meat animal production (Seal, et al.,
2013; Thacker, 2013), exploring the potential of egg byproducts to improve immunity and
disease resistance in poultry is logical. We hypothesized that the factors present in the ESM may
help modulate immunity and performance of chickens if provided as post hatch nutrient
supplements which is the objective of this study.
MATERIALS AND METHODS
Preparation of eggshell and ESM
Unfertilized fresh eggs removed of albumen and yolk were washed by mild scrubbing inside of
the shell under running water and peeled to obtain membranes. The membranes were washed by
stirring with excess water for 2-3 hours, lyophilized, and finally ground to powdery flakes using
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a commercial blender. To determine the membrane yield, the individual eggs and their
membranes were processed separately. For preliminary trials, ESM and whole shells with or
without membranes were ground separately, and used as supplements to evaluate their effects on
chicken performance using BW and relative organ weights as the variables.

The above

preparations were mixed with the grower diet formulated per NRC specification (NRC, 1994)
using a feed mixer. The amount of eggshell and ESM were set to the concentrations of 5% whole
shell, 4.8% shell without membrane, and 0.2% ESM based on the observation that a large egg
yields approximately 5-6 g shell and 0.2-0.25 g of ESM. Based on those initial trials, subsequent
studies were done using only the ESM preparations at 0.2 and 0.4% levels, respectively
ESM and feed analysis
The nitrogen (N), calorie, and selective mineral content of ESM supplemented feed were
analyzed in the Central Analytical Laboratory of the University of Arkansas using randomly
sampled ESM powder and feed. Dumas N analyzer, bomb calorimeter, and inductively coupled
plasma spectroscopy (ICP) were used for respective analyses.
Chicken treatments
Studies were approved by the University of Arkansas, Institutional Animal Care and Use
Committee. In all trials day-old male broiler chicks from local hatchery (Cobb) were used. In the
preliminary trial, the birds were divided into 3 groups consisting of 16 birds each, placed in 2
replicate battery cages, and provided ad libitum access to feed and water. The chickens were
provided specified diets from day 1 through 14 and regular diets thereafter till the termination of
experiments. The follow up and final trial reported here was done using ESM at 2
concentrations, 0.2% and 0.4%, respectively. Birds were monitored daily for mortality and
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welfare. The BW of the chickens were measured at the beginning and at weekly intervals
thereafter. All birds were necropsied at three weeks of age. Blood collection and organ weight
On day 21, the chickens were weighed and 6 from each of the replicate cages were bled by
cardiac puncture; the blood was collected in Vaccutainer tubes containing EDTA for hematology
and clot accelerator for serum clinical chemistry analyses. The chickens were killed by cervical
dislocation and the weights of liver, heart, spleen, and bursa recorded, and calculated as
percentage of BW. The blood with clot accelerator were kept at room temperature for 2 hours,
centrifuged at 2,500g to separate serum, and stored in aliquots at -20 °C until the assays were
done.

Hematology
Hematology measurements were done with EDTA anti-coagulated blood within 2 h of bleeding
using a Cell-Dyn 3500 blood analysis system (Abbott Diagnostics, Abbott Park, IL),
standardized for avian blood. The white blood cell (WBC), heterophil (H), lymphocyte (L),
monocyte (M), eosinophil (E), basophil (B), red blood cell (RBC), and thrombocyte counts,
hemoglobin, hematocrit, mean corpuscular volume (MCV), microhematocrit (MCH), red blood
cell distribution width (RDW) values were measured, and the heterophil to lymphocyte ratios
(H/L) calculated.

Serum chemistry, corticosterone, IgG, and IgM determination
The serum was used to determine clinical chemistry variables using a clinical chemistry analyzer
(Ciba Corning Diagnostics Corp; Medfield MA). The parameters included protein, glucose,
cholesterol, calcium, phosphorous, magnesium, triglycerides, blood urea nitrogen (BUN),
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alanine aminotransferase (ALT), aspartyl aminotransferase (AST), gamma glutamyl transferase
(GGT), creatinine, creatine kinase, and alkaline phosphatase. Serum corticosterone levels were
measured using a Detect X enzyme immunoassay kitTM purchased from Arbor Assays (Ann
Arbor, MI). Serum samples from 12 birds in each group were diluted 1:20 using the assay buffer
provided in the kit, and the immunoassay done per instructions in the kit. The concentrations of
corticosterone in serum samples were calculated from a standard curve obtained using the
supplied standard. The results were expressed as nanograms of corticosterone per ml. Similarly,
the IgM and IgG concentrations of the sera were determined in triplicates using reagents
obtained from Bethyl Laboratory (Montgomery, TX), following the suggested instructions. Eight
well strips (BD Falcon) were coated with either goat anti chicken IgM or IgG antibodies and the
assays performed per respective instructions using sera diluted to 1:20,000 for IgM and 1:5000
for IgG as determined in preliminary assays. The goat anti chicken IgM- or IgG-horse radish
peroxidase (HRP) were used as secondary antibodies respectively. The HRP enzyme activity
was measured using tetramethylbenzidine (TMB) substrate as the end point. The concentrations
of antibodies in the sera were calculated from their respective standard curves obtained using a
reference calibrator serum supplied in the kit. The results were reported as mg/ml serum.

Statistical analyses
The relative organ weights were calculated as percentage of whole BW. All results were
evaluated using Duncan's multiple range test using SAS software (SAS, 2009) and a P-value of
<0.05 considered significant.
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RESULTS
The preliminary trial with shell with or without membranes caused a substantial reduction in the
BW while ESM alone supported growth (not shown). Similarly, the relative weights of both
heart and liver increased significantly in groups receiving feed with shell containing preparations
indicating their toxic effects. The chickens receiving feed supplemented with ESM only did not
show any change in relative organ weights (not shown). The results of the final trial are shown
later.
The analysis of ESM showed the N content ~86 % of total mass. When ESM added at 0.2% or
0.4% levels to feed, showed negligible differences compared with the total protein, caloric, or
elemental content of regular diet (Table 1).
Mortality, health, and BW
Chickens fed control or ESM supplemented diets showed no mortality during the trial. The birds
in overall appeared healthy and alert with no signs of sickness or lethargy. The BW showed
increased differences in birds fed 0.4% ESM supplemented diet starting from first week of
growth (Fig 1). At final week both treatments showed statistically higher BW relative to the
controls. The BW and relative organ weight changes are shown in Table 2. There were no
changes in relative heart, liver, spleen, and bursa weights of birds fed ESM supplemented diet
compared with controls.
Blood Differential count

88

There was a significant increase in WBC, lymphocyte, RBC, and HCT values, and a decrease in
monocyte counts of chickens fed 0.4% ESM compared with controls. In chickens receiving 0.2%
ESM there was no significant change in blood cell counts except for monocytes which decreased
as compared with control birds (Table 3).
Serum clinical chemistry, corticosterone, IgM, and IgG assays
Except for the total protein content of serum there were no changes in any of the clinical
chemistry parameters including AST, ALT, GGT, BUN, uric acid, Ca, or P (Table 4). IgM and
IgG content showed significant increases in the sera of chickens fed both 0.2% and 0.4% levels
of ESM (Fig 2). The corticosterone levels on the contrary, showed significant reduction in the
sera of birds fed 0.4% ESM supplemented diet and numerically lower at 0.2% level (Fig 3).

DISCUSSION
Salvaged egg byproducts from defective eggs have been shown to improve livestock
performance based on their nutritive values (Al-Harthi, et al., 2011; Schmidt, et al., 2007). But
the use of eggshell membranes as feed supplements has been little explored. Considering the
large numbers of immunomodulatory proteins and peptides that are present in shell membrane
(Cordeiro and Hincke, 2011; Miksík, et al., 2007; Mine, 2007), we hypothesized that ESM may
have beneficial effects on the physiology of chickens. Inclusion of ESM in the diet not only
caused a moderate to significant weight gain but also elevated both serum IgM and IgG levels
indicative of modulation of humoral immunity. There was no change in relative weights
suggestive of any negative or inflammatory effect of ESM. The changes in some blood cell
parameters such as WBC and lymphocyte counts that were increased with 0.4% ESM fed birds
along with their antibody (IgM and IgG) response, may suggest a stimulation of their adaptive
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immune response. Although the monocyte counts decreased at both treatment levels, the
heterophil counts and H/L ratio showed only numerical decrease at 0.4% levels of ESM. Stress
is a major factor that decreases monocyte counts. Our results showed that the blood
corticosterone levels were reduced in chickens fed ESM diets suggesting a lower levels of stress
in these birds although the mechanism for its decrease is not understood. Stress and
inflammation can also cause a loss of BW and present other signs of sickness such as lethargy
that was not observed in ESM fed birds. Low levels of stress can also imply better feeding
behavior (Bunnett, 2005) that would contribute to increase in BW. The sickness was also not
evident from clinical chemistry variables such as the AST, ALT, and GGT values which are
linked to hepatic dysfunction and poultry myopathy (MacRae, et al., 2006). Similarly, there was
no elevation in the levels of blood urea nitrogen (BUN), uric acid, and creatinine that would
indicate kidney dysfunction or creatine kinase which is a sign of muscle dysfunction. The
increases in blood lymphocyte, IgG, and IgM levels indicate a modulation of immunity as
compared with control birds. IgM is a natural antibody produced by B1 lymphocytes that fights
infection, prevents inflammation, reacts with a variety of foreign antigens including pathogen
associated molecules, activates complement, foreruns, and stimulates IgG response (Boes, 2000;
Ehrenstein and Notley, 2010; Grönwall and Silverman, 2014). Similarly, an increase in the levels
of IgG in ESM fed chickens also suggests a modulation of adaptive immune response. These
antibodies play vital roles for protection against a variety of microbial pathogens (Jeurissen, et
al., 2000; Sharma, 1997). Whether the antibody response to ESM is transient or it establishes a
lasting resistance to certain infection needs to be verified.
The shell membrane is a highly crosslinked matrix that contains many proteins and peptides such
as defensins which can potentially behave as adjuvants (Brown and Hancock, 2006; Zhang, et
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al., 2010).

It can also bind and carry foreign antigens to provide vaccine-like effects.

Lactotransferrin, same as ovotransferrin in ESM, was shown to help maturation of dendritic cells
of intestine and improve gut immunity (Spadaro, et al., 2008; Spadaro, et al., 2014). Chickens
fed genetically engineered rice, expressing lactoferrin and lysozyme, showed improvement of
gastrointestinal function with antibiotic-like effects (Humphrey, et al., 2002). Lysozyme was also
shown to have similar effects in pig (Oliver and Wells, 2013).
One of the major imperatives of meat-animal production is to improve immunity (disease
resistance) without sacrificing growth while abstaining from the use of antibiotics. The ESM
supplement appears to have beneficial effect in chickens while it reduces stress and modulates
immunity without sacrificing the growth potential of the birds.
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Table 1. Protein, calorie and selective elemental content of regular and ESM supplemented
Variables

Control Feed

Control Feed

Control Feed

+ESM 0.2%

+ESM 0.4%

Protein (%)

22.1

22.2

22.2

Calories/kg

4252

4221

4212

Calcium (ppm)

11531

11524

11037

Magnesium (ppm)

1552

1602

1619

Sodium (ppm)

1511

1469

1339

Phosphate (ppm)

8074

7852

7668

Sulfur (ppm)

2284

2347

2357

Zinc (ppm)

134

115

116
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Table 2. BW and the relative organ weights of chicken fed diets with and without ESM (n=16)
Parameters

Control

+ESM 0.2%

+ESM0.4%

905.38±18.35b

967.50±12.97a

958.00±16.89a

Relative heart
weight (%)

0.50±0.01a

0.54±0.02a

0.54±0.01a

Relative liver
weight (%)

2.21±0.07a

2.46±0.20a

2.25±0.05a

Relative spleen
weight (%)

0.08±0.01a

0.10±0.01a

0.11±0.01a

Relative bursa
weight (%)

0.16±0.01a

0.17±0.01a

0.20±0.01a

Body weight
(grams)

Values with different superscripts in a row are significantly different (P<0.05).
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Fig 1. Effect of ESM supplement on weekly BW (n=16). *denotes statistically significant
differences (p< 0.05) compared with the control fed chickens. The BW of chickens fed both
levels of ESM supplemented diets showed statistically significant increases at 3-wk of age
indicated by **.
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Table 3. Hematology profiles of chickens fed with and without ESM supplemented feed
(n=12)
Variables

Control

+ESM 0.2%

+ESM 0.4%

White blood cell
(WBC) (x103/µL)

28.61±2.87b

35.45±2.25b,a

37.5±2.30a

Heterophil (%)

14.83±1.30a

11.96±1.22a,b

11.2±1.19a,b

Lymphocyte (%)

74.81±2.02b

80.0±1.77b,a

81.6±1.55a

Monocyte (%)

8.02±0.84a

5.53±0.70b

4.95±0.37b

Eosinophil (%)

0.02±0.01a

0.02±0.01a

0.02±0.00a

Basophil (%)

2.34±0.12a

2.50±0.14 a

2.17±0.18a

Red blood cell (RBC)
(× 106/µL)

2.08±0.02b

2.09±0.03b

2.2±0.03a

Thrombocyte (k/µL)

13.36±0.65a

11.81±0.70a,b

9.93±0.39b

0.16±0.02a

0.14±0.02a,b

Heterophil/Lymphocyte 0.21±0.03a
(H/L)
Hemoglobin (g/dL)

7.00±0.10a

6.92±0.09a

7.06±0.08a

Hematocrit (%)

52.78±0.67b

52.65±0.77b

55.67±0.68a

Mean corpuscular
volume (MCV) (fL)

254.06±1.66a

252.33±0.82a

257.40±1.68a

11.79±0.11a

11.91±0.14a

Red cell distribution 11.76±0.16a
width (RDW) (%)

Values with different superscripts in a row are significantly different (P<0.05)
Table 4. Clinical chemistry variables of serum from 3 wk-old chickens fed with or without ESM
(n=12)
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Parameters

Control

+ESM 0.2%

+ESM 0.4%

Albumin (g/dL)

0.98±0.03b

1.03±0.08b

1.05±0.02b,a

Alkaline phosphate
(U/L)

757.83±139.78a

958.75±186.52a

797.58±168.70a

Alanine transferase
(U/L)

2.61±0.51a

2.08±0.57a

2.65±0.37a

194.02±6.16a

193.63±5.46a

189.60±4.64a
Aspartate
aminotransferase(U/L)
Blood urea nitrogen
(mg/µL)

1.12±0.09a

1.12±0.11a

1.19±0.43 a

Calcium (mg/dL)

8.80±0.16a,b

9.11±0.21a

8.47±0.13b

Cholesterol (mg/dL)

107.50±3.27a

110.50±5.89a

109.17±3.46a

Creatinine kinase
(U/L)

177.08±22.97a

150.75±25.56a

267.25±61.65a

Creatinine (mg/dL)

0.31± 0.02a

0.27±0.02a

0.28±0.02a

Gamma-glutamyl
transferase (U/L)

14.41±5.13a

14.25±0.70a

14.9±0.57a

Glucose (mg/dL)

230.41±5.13a

240.08±5.90a

238.17±0.06a

Phosphorous (mg/dL)

4.33±0.08a

4.46±0.23a

4.45±0.06a

Low density
lipoprotein (mg/dL)

115.50±13.03a

119.75±10.34a

133.33±10.13a

Total protein (g/dL)

2.23±0.04c

2.85± 0.09b

3.18±0.04a
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Triglycerides (mg/dL)

54.17±4.75a

62.58± 6.58a

62.75±6.91a

Uric Acid (mg/dL)

5.87±0.23a

6.23±0.29a

5.97±0.32a

Magnesium (mEq/L)

1.60±0.05a

1.60±0.05a

1.67±0.03a

Iron (µg/dL)

84.40±3.97a

86.55±7.12a

82.50±3.70a

Values with different superscripts in a row are significantly different (P<0.05)

Fig 2. Comparison of serum IgM and IgG levels of chickens fed control, 0.2%, and 0.4% ESM
supplemented diets. The IgM and IgG levels were measured as mg/ml ± SEM (n=12 each).
Values with different superscripts are significantly different (P<0.05).
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Fig 3. Serum corticosterone levels of chickens fed diets supplemented with or without ESM. The
concentration of corticosterone was measured as ng/ml and shown as mean ± SEM. Values with
different superscripts are significantly different (P<0.05).
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Abstract
Eggshell membranes protect growing embryo are interlaced around the albumen and form a
meshwork, which can trap the invading bacteria and prevent it from further penetrating in the
egg. The microstructures present on egg membranes are formed of these fibrous proteins, which
are knotted together to form a net to obstruct the passage of microorganisms. We hypothesize
that eggshell membranes from hatched eggs will be richer in fetal proteins and their
characterization possibly might shed light into their biological relevance in providing physical
and chemical defense to the growing embryo. We want to explore the eggshell membranes in the
context of waste material left after the eggs are hatched. We extracted the proteins and peptides
by two methods and analyzed them with mass spectrometry techniques. The proteins and
peptides from hatched eggshell membranes (HESM) were extracted with methanol and also with
a chaotropic agent. Both the extracts were subjected to in solution digestion, the protein and
peptide profiles were determined by LC-MS/MS. The results from hatched egg membranes
showed the presence of not only the presence of proteins (ovalbumin, ovocledin, lysozyme)
which is found in unfertilized egg membranes but also many new proteins such as zona pleucida,
filamin, lumican which can be major players in the growth, and development of the embryo.

Introduction
Egg shells from hatchery waste have been considered to be useful for biological and biomedical
applications (Abeyrathne, et al., 2013; Kovacs-Nolan, et al., 2005) . The empty egg shells largely
consist of the outer calcareous matrix and underlying membranes that are not only proteinaceous
but laced with many proteins of embryonic origins as well as a variety of microbial and hatchery
contaminants (Das, et al., 2002; Mine, et al., 2003). The embryonic proteins and peptides may
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be useful to bring about specific physiological modulation; however, their potential has not been
tested. Previously, we found that shell membranes prepared from unfertilized eggs when fed to
chickens post hatch for 2 weeks affected their growth performance, and immunity (Makkar, et
al., 2015b) these membranes were abound with numerous antimicrobial and cell associated
peptides (Makkar, et al., 2015a). Following those studies we observed that hatchery egg shell
membrane (HESM) fed to post hatch chickens not only improved growth performance but also
protected

the

chickens

against

lipopolysaccharide

(LPS)

induced

anorexia/cachexia

(unpublished). Considering that the differences between 2 membrane preparations can be
considerable such as the unfertilized egg shell membrane may have only certain types of proteins
and peptides inherently acquired from reproductive tract, whereas the HESM may have been
differentially enriched with proteins of embryonic, blood, feather, and microbial origins, we were
interested to determine their protein profile. The results of these studies are described in the
current report.

Chemicals and reagents.

All reagents and devices such as C18 Nu tips (Glysci.com),

Spectra/Por membranes (Spectrumlabs.com), BCA protein assay kit, Pierce C18 spin columns,
MS grade trypsin (Fisher Scientific.com), peptide

calibration standard II (m/z 500-16000,

Bruker Daltonics, Bremen, Germany), and 2-iodoacetamide (IAA) (MP Biomedicals, OH) were
purchased from their respective vendors. All other reagents and supplies including 1, 4dithiothreitol (DTT), 2, 5-dihydroxybenzoic acid (DHB), were purchased from Sigma Aldrich
(St. Louis, MO).

Material and methods
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Empty eggshell with membranes were obtained from a local hatchery and allowed to dry at room
temperature under the hood. The membranes were separated manually and ground to a powdered
form using an IKA mill (find specification). The membrane powders were extracted with 4 M
guanidine hydrochloride (GdHCl) containing 20 mM EDTA, and 50 mM Na-acetate, pH 5.8 and
70% methanol containing 0.1% acetic acid stirred in 20 volumes of respective solutions
overnight at 4o C. The extracts were centrifuged at 21,000 g for 15 min, and the supernatant
dialyzed against excess 50 mM ammonium carbonate solution with 3 changes using 1,000 Da
Spectra/Por membranes. The protein concentrations of both the extracts were measured using
BCA protein assay kit. The extracts were concentrated by vacuum evaporation by means of a
speed vac or lypholization and approximately 50 µg of both were reduced, alkylated and trypsin
digested and desalted with C18 columns and subjected to LC/MS/MS. Each of these extractions
was done in 2 trials and the studies were repeated twice.

LC-MS/MS analysis of methanol and guanidine extracted proteins. The protein
concentrations of GdHCL was adjusted to 5mg/ml. Approximately 50 µg of GdHCl extracted
proteins was subjected to reduction and alkylation, and digested with trypsin at the protein:
trypsin ratios of 50:1 for 24 h at 37oC . The tryptic digest was desalted with Pierce C18 spin
columns and chromatographed on a capillary C18 column (150 x 0.1 mm, 3.5 µm particle size,
300 Å pore size, Zorbax SB) attached to an Agilent 1200 series HPLC, interfaced with a Bruker
Amazon-SL quadrupole ion trap mass spectrometer, and captive spray source. Tryptic peptides
were separated at a solvent flow rate of 1.6 µL/min with 0 to 40 % gradients of 0.1% FA (solvent
A) and ACN in 0.1% FA solvent B (solvent B). Each time the samples were run three times as
technical repeats and the results from 2 replicate studies were processed using Skyline software
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(https://skyline.gs.washington.edu/labkey/project/home/begin.view) for peptide dominance and
scores automatically without introducing any manual bias. The same strategy was applied to the
methanol extract of HESM.
LC-MS/MS analyzed proteins. Peaks were picked in the LC-MS/MS (MSn) chromatogram
using Bruker default settings. Bruker Proteinscape bioinformatics suite coupled with MASCOT
2.1 was used to search NCBI Gallus protein database for identification. The parent ion mass
tolerance and fragment ion mass tolerance were both set at 0.6 Da. A MASCOT decoy database
search was performed with all the datasets. A score threshold of 45 or more was used as a high
probability match for protein identifications. The proteins with only <1% false discovery rate
(FDR) and at least 1unique peptide were reported. Functional annotation for these proteins was
performed using Gene Ontology tool powered by PANTHER (http://geneontology.org)

Results
The guanidine HCl extract of HESM showed the presence of more than 100 proteins (Table 1)
and 47 proteins (Table 2) in the methanol. Along with ovoalbumin, ovolcledin which are present
in ESM, the membranes from fertilized eggs also contains tubulin, annexin, collagen, titin,
desmin in abundance. Several chaperon proteins such as heat shock 10, 60 and 70 are also found.
Proteins associated with antimicrobial properties such as lysozyme, gallinacin, keratin, cystatin
are also reported. Some of the proteins are unique in methanol extract, which are not found in
gunadine HCl extract such as gallinacin 9, thymosin beta 4, septins. The functional annotation
by PANTHER shows that most of the proteins are involved in metabolic and cellular processes
in terms of their biological relevance. In terms they are mainly involved of their molecular
function Structural, binding and catalytic activity. We also found 50 proteins of bacterial origin,
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which gives us a clue that these membranes acts as a trap for bacteria and prevent their egression
inside the egg and acts as both physical and chemical barrier for the growing embryo.
Discussion
Cordieri et.al also reported the presence of fibronectin, vitellogenin, apolipoproteins in fertilized
ESM (Cordeiro and Hincke, 2015) . The fertilized membranes are more rich in cytoskeleton
proteins such as stratifin, fibronectin, annexin. Fibronectin plays very important role in
embryogenesis and it is involved in the cell migration, attachment and differentiation during the
process of growth of an embryo. (Nicosia, et al., 1993) (Risau and Lemmon, 1988).
Defensins are an important category of antimicrobial peptides that contains highly conserved
cysteine residues. They are important arsenals of our innate immune system cells and are
multifunctional in nature. The chemotactic properties of defensins helps in the recruitment of the
immune cells to the site of infection, eliminate the pathogens and modulate the immune system.
(Guaní-Guerra, et al., 2010; Hazlett and Wu, 2011; Jäger, et al., 2012). Gallin, a member of
defensin family found in egg white and now also reported in membranes have potent
antimicrobial activity against E.coli (Gong, et al., 2010).
Actin, mimecan, apolipoprotein, annexin, lumican are involved in developmental process.
Mimecan is unique to fertilized membranes and is extracellular matrix glycoprotein, involved in
the formation of tissues (Funderburgh, et al., 1997). Lumican another extracellular protein is
clinically significant in term of providing transparency to the cornea by aligning with collagen
fibrils (Kao, et al., 2006; Wang, et al., 2014). Lum knock out mice are reported to have
abnormality in skin, heart tissues and cornea (Chakravarti, 2002)
Thioredoxin, lactate dehydrogenase, serpin are major players in catalytic activity. Thioredoxins
are antioxidants and help to prevent oxidative stress (Lu and Holmgren, 2014; Nordberg and
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Arnér, 2001). Serpins are protease inhibitors and also important constituents of blood clotting
and inflammation processes (Devlin and Bottomley, 2005; Rau, et al., 2007). Proteins are actual
functional molecules and indicators of pathological condition or pharmacological process and
can be good candidates to target for drug designing. Understanding the constituent proteins and
peptides may shed light into their functions associated with the development and protection of
the embryo and improve egg quality.
The biological interpretation of the proteomic dataset in itself is a big challenge. Therefore
analysis of each single protein by referring to the literature is a limiting factor, in finding the
insights of the functional aspect of these proteins. (Fredrickson, et al., 2013) (Thompson, et al.,
2012). But still with the annotation software’s we can broadly classify these proteins into
categories based on their roles in growth, development and several other metabolic functions.
Functional analysis of HESM proteins showed that majority of them is involved in cellular
process, regulation and also development process.
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Table 1: Proteins identified in methanol extract by LC-MS/MS
ID
ENSGALP00000000275
ENSGALP00000000325
ENSGALP00000000726
ENSGALP00000000876
ENSGALP00000001532
ENSGALP00000002523
ENSGALP00000005544

ENSGALP00000006093
ENSGALP00000006097
ENSGALP00000008163
ENSGALP00000009976

ENSGALP00000010763
ENSGALP00000012729
ENSGALP00000013908
ENSGALP00000014919
ENSGALP00000016177

DED Description esDescrDescription
Ovalbumin [Source:UniProtKB/SwissProt;Acc:P01012]
Ovomucoid [Source:UniProtKB/SwissProt;Acc:P01005]
Ovocleidin-116
[Source:UniProtKB/SwissProt;Acc:F1NSM7]
orosomucoid 1 (ovoglycoprotein)
precursor [Source:RefSeq
peptide;Acc:NP_989872]
peptidyl-prolyl cis-trans isomerase
FKBP1A [Source:RefSeq
peptide;Acc:NP_989661]
Lysozyme C
[Source:UniProtKB/SwissProt;Acc:P00698]
keratin 8, type II [Source:HGNC
Symbol;Acc:HGNC:6446]
Gallus gallus SH3 domain binding
glutamic acid-rich protein like
(SH3BGRL), mRNA. [Source:RefSeq
mRNA;Acc:NM_001012574]
Ubiquitin-fold modifier 1
[Source:UniProtKB/SwissProt;Acc:Q5ZMK7]
Gallinacin-9
[Source:UniProtKB/SwissProt;Acc:Q6QLR1]
Ovocalyxin-36 precursor
[Source:RefSeq
peptide;Acc:NP_001026032]
Gallus gallus diazepam binding inhibitor
(GABA receptor modulator, acyl-CoA
binding protein) (DBI), mRNA.
[Source: RefSeq
mRNA;Acc:NM_204576]
Gallinacin-10 [Source:
UniProtKB/Swiss-Prot;Acc:Q6QLQ9]
keratin, type I cytoskeletal 19 [Source:
RefSeq peptide;Acc:NP_990340]
Usher syndrome 1C [Source: HGNC
Symbol;Acc:HGNC:12597]
Uncharacterized protein [Source:
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scores

mw

#Peptides

629.9

42.9 11

338.1

22.6 7

225

76.8 2

167

22.3 3

163.5

8.9 3

129.2

16.2 2

119.1

42.1 2

109.6

12.9 2

102.1

9 1

85.7

7.3 2

83.7

58.3 1

69.8

9.6 2

62.6

7.1 2

62.3

46 3

51.9
50.9

100.1 1
21 1

ENSGALP00000016632
ENSGALP00000017755
ENSGALP00000018601
ENSGALP00000019412
ENSGALP00000019758
ENSGALP00000019988
ENSGALP00000020194
ENSGALP00000024777
ENSGALP00000025120
ENSGALP00000025439
ENSGALP00000026777
ENSGALP00000026846
ENSGALP00000026863
ENSGALP00000027483
ENSGALP00000027541
ENSGALP00000030659
ENSGALP00000031518
ENSGALP00000031725

UniProtKB/TrEMBL;Acc:E1C8H4]
thymosin, beta 4 [Source:RefSeq
peptide;Acc:NP_001001315]
collagen, type XVI, alpha 1 [Source:
HGNC Symbol;Acc:HGNC:2193]
signal peptidase complex subunit 1
homolog [Source: RefSeq
peptide;Acc:NP_001165115]
zinc finger BED domain-containing
protein 4 [Source: RefSeq
peptide;Acc:NP_001186470]
alpha-D-globin (HBAD), mRNA.
[Source: RefSeq
mRNA;Acc:NM_001004375]
utrophin [Source: HGNC
Symbol;Acc:HGNC:12635]
fatty acid-binding protein, heart
[Source: RefSeq
peptide;Acc:NP_001026060]
nociceptin precursor [Source: RefSeq
peptide;Acc:NP_001171980]
polycystic kidney and hepatic disease 1
(autosomal recessive) [Source: HGNC
Symbol;Acc:HGNC:9016]
serine peptidase inhibitor, Kazal type 2
(acrosin-trypsin inhibitor) [Source:
HGNC Symbol;Acc:HGNC:11245]
probable arginyl-tRNA synthetase,
mitochondrial [Source: RefSeq
peptide;Acc:NP_001264948]
transforming, acidic coiled-coil
containing protein 1 [Source: HGNC
Symbol;Acc:HGNC:11522]
elaC ribonuclease Z 2 [Source :HGNC
Symbol;Acc:HGNC:14198]
Fibroblast growth factor 2 [Source:
UniProtKB/Swiss-Prot;Acc:P48800]
nuclear receptor coactivator 2 [Source:
HGNC Symbol;Acc:HGNC:7669]
WD repeat-containing protein 36
[Source:RefSeq
peptide;Acc:NP_001038099]
large tumor suppressor kinase 1
[Source:HGNC
Symbol;Acc:HGNC:6514]
septin 3 [Source:HGNC
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47.8

5 2

42

156.6 1

37.9

27.2 1

37.8

132.4 2

37.3

15.7 1

36.5

398.6 2

34.6

14.8 1

34.4

21.4 1

32.7

440 1

26.7

6 1

25.2

65.3 1

24.5

86.4 2

24.2

94.2 1

22.8

16.2 1

21.5

44.7 1

21.2

98.2 1

21.2
20.5

127.7 1
40 1

ENSGALP00000035930

ENSGALP00000036403
ENSGALP00000038283
ENSGALP00000038735
ENSGALP00000038904
ENSGALP00000038912
ENSGALP00000039913
ENSGALP00000040476

Symbol;Acc:HGNC:10750]
High mobility group protein B1
[Source:UniProtKB/SwissProt;Acc:Q9YH06]
tRNA (adenine-N(1)-)methyltransferase non-catalytic subunit
TRM6 [Source:RefSeq
peptide;Acc:NP_001026212]
fibrinogen silencer binding protein
[Source:HGNC
Symbol;Acc:HGNC:43653]
SH3 domain binding glutamate-rich
protein like 3 [Source:HGNC
Symbol;Acc:HGNC:15568]
UPF3 regulator of nonsense transcripts
homolog B (yeast) [Source:HGNC
Symbol;Acc:HGNC:20439]
mutated in colorectal cancers
[Source:HGNC
Symbol;Acc:HGNC:6935]
Polyubiquitin-B Ubiquitin
[Source:UniProtKB/SwissProt;Acc:P0CG62]
neuregulin 2 [Source:HGNC
Symbol;Acc:HGNC:7998]
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20

24.9 1

19.8

54.2 1

19

36.4 1

18.8

10.5 1

18.4

56.9 1

18.3

112.6 1

15.5

109.6 1

15

65.5 1

Table 2: Proteins identified in guanidine HCL extract of eggshell membranes by LC-MS/MS
Protein id
ENSGALP00000010
405
ENSGALP00000036
403
ENSGALP00000039
176
ENSGALP00000005
654
ENSGALP00000019
372
ENSGALP00000016
648
ENSGALP00000015
988
ENSGALP00000006
093
ENSGALP00000005
836
ENSGALP00000016
632
ENSGALP00000006
090
ENSGALP00000015
687
ENSGALP00000038
912
ENSGALP00000005
971
ENSGALP00000016
177
ENSGALP00000035
593

Description
ovotransferrin precursor
[Source:RefSeq
peptide;Acc:NP_990635]
Ovalbumin [Source:UniProtKB/SwissProt;Acc:P01012]
Actin, cytoplasmic type 5
[Source:UniProtKB/SwissProt;Acc:P53478]
fibronectin precursor [Source: RefSeq
peptide;Acc:NP_001185641]
protein-glutamine gammaglutamyltransferase 4 [Source:RefSeq
peptide;Acc:NP_001006368]
Actin, alpha cardiac muscle 1 [Source:
UniProtKB/Swiss-Prot;Acc:P68034]
keratin, type I cytoskeletal 19 [Source:
RefSeq peptide;Acc:NP_990340]
keratin, type I cytoskeletal 14-like
[Source: RefSeq
peptide;Acc:NP_001264913]
keratin 8, type II [Source: HGNC
Symbol;Acc:HGNC:6446]
keratin, type I cytoskeletal 14
[Source:RefSeq
peptide;Acc:NP_001001311]
collagen alpha-2(I) chain precursor
[Source:RefSeq
peptide;Acc:NP_001073182]
Gallus gallus alpha-D-globin (HBAD),
mRNA. [Source:RefSeq
mRNA;Acc:NM_001004375]
Annexin A2
[Source:UniProtKB/SwissProt;Acc:P17785]
Lysozyme C
[Source:UniProtKB/SwissProt;Acc:P00698]
Hemoglobin subunit beta
[Source:UniProtKB/Swiss112
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# Peptides
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Prot;Acc:P02112]
Uncharacterized protein
[Source:UniProtKB/TrEMBL;Acc:H9
KZP6]
serum albumin precursor
[Source:RefSeq
peptide;Acc:NP_990592]
Gallus gallus hemoglobin, alpha 1
(HBAA), mRNA. [Source:RefSeq
mRNA;Acc:NM_001004376]
decorin precursor [Source:RefSeq
peptide;Acc:NP_001025918]
vimentin [Source:RefSeq
peptide;Acc:NP_001041541]
Gallus gallus ATP synthase, H+
transporting, mitochondrial F1
complex, beta polypeptide (ATP5B),
nuclear gene encoding mitochondrial
protein, mRNA. [Source:RefSeq
mRNA;Acc:NM_001031391]
epsilon globin [Source:RefSeq
peptide;Acc:NP_001026660]
keratin, type I cytoskeletal 15 [Source:
RefSeq peptide;Acc:NP_001001312]
titin [Source:HGNC
Symbol;Acc:HGNC:12403]
Gallus gallus histone cluster 1, H4-VI,
germinal H4 (similar to human histone
cluster 1, class H4 genes) (HIST1H46),
mRNA. [Source: RefSeq
mRNA;Acc:NM_001037845]
zona pellucida sperm-binding protein 1
precursor [Source: RefSeq
peptide;Acc:NP_990014]
alpha-enolase [Source: RefSeq
peptide;Acc:NP_990451]
keratin 6A [Source: RefSeq
peptide;Acc:NP_001001313]
Tropomyosin alpha-1 chain [Source:
UniProtKB/Swiss-Prot;Acc:P04268]
myeloid protein 1 precursor [Source:
RefSeq peptide;Acc:NP_990809]
transgelin 2 [Source: HGNC
Symbol;Acc:HGNC:11554]
Glyceraldehyde-3-phosphate
dehydrogenase [Source:
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UniProtKB/Swiss-Prot;Acc:P00356]
annexin A1 [Source: RefSeq
peptide;Acc:NP_996789]
Zona pellucida sperm-binding protein 3
Processed zona pellucida spermbinding protein 3 [Source:
UniProtKB/Swiss-Prot;Acc:P79762]
Elongation factor 1-alpha 1
[Source:UniProtKB/SwissProt;Acc:Q90835]
Gallus gallus histone cluster 1, H1.01
(similar to human histone cluster 1,
class H1 genes) (HIST1H101), mRNA.
[Source: RefSeq
mRNA;Acc:NM_001040642]
peptidyl-prolyl cis-trans isomerase A
[Source: RefSeq
peptide;Acc:NP_001159798]
Apolipoprotein A-I Proapolipoprotein
A-I [Source: UniProtKB/SwissProt;Acc:P08250]
keratin 18, type I [Source:HGNC
Symbol;Acc:HGNC:6430]
Lumican [Source: UniProtKB/SwissProt;Acc:P51890]
Annexin [Source:
UniProtKB/TrEMBL;Acc:E1C8K3]
Ovocleidin-116 [Source:
UniProtKB/Swiss-Prot;Acc:F1NSM7]
heat shock 70 kDa protein [Source:
RefSeq peptide;Acc:NP_001006686]
tubulin beta-3 chain [Source: RefSeq
peptide;Acc:NP_001074329]
gelsolin precursor [Source: RefSeq
peptide;Acc:NP_990265]
Ovomucoid [Source:
UniProtKB/Swiss-Prot;Acc:P01005]
Serpin H1 [Source: UniProtKB/SwissProt;Acc:P13731]
Fructose-bisphosphate aldolase C
[Source: UniProtKB/SwissProt;Acc:P53449]
keratin 4, type II [Source:HGNC
Symbol;Acc:HGNC:6441]
heat shock cognate 71 kDa protein
[Source: RefSeq
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peptide;Acc:NP_990334]
Triosephosphate isomerase [Source:
UniProtKB/Swiss-Prot;Acc:P00940]
Gallus gallus actinin, alpha 4
(ACTN4), mRNA. [Source :RefSeq
mRNA;Acc:NM_205126]
creatine kinase B-type [Source: RefSeq
peptide;Acc:NP_990641]
proline/arginine-rich end leucine-rich
repeat protein [Source: HGNC
Symbol;Acc:HGNC:9357]
desmin [Source: HGNC
Symbol;Acc:HGNC:2770]
Pyruvate kinase PKM [Source:
UniProtKB/Swiss-Prot;Acc:P00548]
Histone H2B [Source:
UniProtKB/TrEMBL;Acc:F1NF30]
destrin [Source: RefSeq
peptide;Acc:NP_990859]
Uncharacterized protein [Source:
UniProtKB/TrEMBL;Acc:E1C6R9]
Beta-galactoside-binding lectin
[Source: UniProtKB/SwissProt;Acc:P07583]
anterior gradient 2 [Source: HGNC
Symbol;Acc:HGNC:328]
14-3-3 protein epsilon [Source:
UniProtKB/Swiss-Prot;Acc:Q5ZMT0]
collagen alpha-1(XII) chain precursor
[Source: RefSeq
peptide;Acc:NP_990352]
H2A histone family, member X
[Source: HGNC
Symbol;Acc:HGNC:4739]
cold-inducible RNA-binding protein
[Source:RefSeq
peptide;Acc:NP_001026518]
orsomucoid 1 (ovoglycoprotein)
precursor [Source:RefSeq
peptide;Acc:NP_989872]
heat shock protein 90kDa alpha
(cytosolic), class A member 1 [Source:
HGNC Symbol;Acc:HGNC:5253]
tropomyosin beta chain [Source:
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RefSeq peptide;Acc:NP_990777]
78 kDa glucose-regulated protein
[Source: UniProtKB/SwissProt;Acc:Q90593]
Thioredoxin [Source:
UniProtKB/Swiss-Prot;Acc:P08629]
collagen alpha-3(VI) chain precursor
[Source:RefSeq
peptide;Acc:NP_990865]
Transgelin [Source: UniProtKB/SwissProt;Acc:P19966]
Ribonuclease homolog
[Source:UniProtKB/SwissProt;Acc:P30374]
ovalbumin-related protein Y [Source:
RefSeq peptide;Acc:NP_001026172]
Histone H2A.Z [Source:
UniProtKB/Swiss-Prot;Acc:Q5ZMD6]
S100 calcium binding protein A12
[Source: HGNC
Symbol;Acc:HGNC:10489]
14-3-3 protein theta [Source:
UniProtKB/Swiss-Prot;Acc:Q5ZMD1]
vitellogenin-2 precursor [Source:
RefSeq peptide;Acc:NP_001026447]
Alpha-fetoprotein [Source:
UniProtKB/TrEMBL;Acc:E1BV96]
stratifin [Source: HGNC
Symbol;Acc:HGNC:10773]
Uncharacterized protein [Source:
UniProtKB/TrEMBL;Acc:F1NZY2]
Gallinacin-10 [Source:
UniProtKB/Swiss-Prot;Acc:Q6QLQ9]
Cystatin [Source: UniProtKB/SwissProt;Acc:P01038]
Myosin regulatory light chain 2,
smooth muscle major isoform
[Source:UniProtKB/SwissProt;Acc:P02612]
fatty acid-binding protein, heart
[Source:RefSeq
peptide;Acc:NP_001026060]
L-lactate dehydrogenase A chain
[Source:RefSeq
peptide;Acc:NP_990615]
60S acidic ribosomal protein P0
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[Source:RefSeq
peptide;Acc:NP_990318]
phosphatidylethanolamine-binding
protein 1 [Source: RefSeq
peptide;Acc:NP_001185571]
Uncharacterized protein [Source:
UniProtKB/TrEMBL;Acc:H9KYP2]
Uncharacterized protein [Source:
UniProtKB/TrEMBL;Acc:R4GMA5]
Mimecan [Source: UniProtKB/SwissProt;Acc:Q9W6H0]
rab GDP dissociation inhibitor beta
[Source: RefSeq
peptide;Acc:NP_990335]
Nucleoside diphosphate kinase
[Source: UniProtKB/SwissProt;Acc:O57535]
annexin A5 [Source: RefSeq
peptide;Acc:NP_001026709]
60S ribosomal protein L8 [Source:
RefSeq peptide;Acc:NP_001264657]
aldehyde dehydrogenase 9 family,
member A1 [Source: HGNC
Symbol;Acc:HGNC:412]
major vault protein [Source: RefSeq
peptide;Acc:NP_001006336]
ribosomal protein L15 [Source: HGNC
Symbol;Acc:HGNC:10306]
Histone H5 [Source: UniProtKB/SwissProt;Acc:P02259]
isocitrate dehydrogenase 1 (NADP+),
soluble [Source: HGNC
Symbol;Acc:HGNC:5382]
transketolase [Source:HGNC
Symbol;Acc:HGNC:11834]
60S ribosomal protein L19 [Source:
RefSeq peptide;Acc:NP_001026100]
Protein S100-A11 [Source:
UniProtKB/Swiss-Prot;Acc:P24479]
Protein disulfide-isomerase A3
[Source: UniProtKB/SwissProt;Acc:Q8JG64]
ribosomal protein S3A [Source:RefSeq
peptide;Acc:NP_001075886]
CD99 antigen precursor [Source:
RefSeq peptide;Acc:NP_001185580]
117

113.9

20.9

4

113.8

67.8

5

113.2

26.7

2

110.1

33.2

3

106.7

50.7

3

104

17.3

4

103.3

36.2

5

102.2

28

4

101.7

57.1

3

96.5

93.7

6

95.8

24.1

2

95.4

20.7

3

93.3

46.9

2

91.9

68.4

3

85.7

23.2

2

85

11.4

1

84.9

56.1

4

84.7

29.8

4

79.3

18.2

2

ENSGALP00000006
938
ENSGALP00000040
966
ENSGALP00000007
490
ENSGALP00000038
677
ENSGALP00000029
440
ENSGALP00000024
468
ENSGALP00000032
611
ENSGALP00000003
455
ENSGALP00000029
968
ENSGALP00000025
929
ENSGALP00000001
013
ENSGALP00000007
680
ENSGALP00000021
618
ENSGALP00000038
462
ENSGALP00000011
689
ENSGALP00000003
431
ENSGALP00000041
639
ENSGALP00000008
131
ENSGALP00000024
078

annexin A6 [Source: RefSeq
peptide;Acc:NP_990061]
Uncharacterized protein [Source:
UniProtKB/TrEMBL;Acc:R4GG07]
moesin [Source: HGNC
Symbol;Acc:HGNC:7373]
Gallus gallus phosphoglycerate mutase
1 (brain) (PGAM1), mRNA. [Source:
RefSeq mRNA;Acc:NM_001031556]
Vitelline membrane outer layer protein
1 [Source: UniProtKB/SwissProt;Acc:P41366]
40S ribosomal protein S15 [Source:
UniProtKB/Swiss-Prot;Acc:P62846]
vitellogenin-1 precursor [Source:
RefSeq peptide;Acc:NP_001004408]
peptidyl-prolyl cis-trans isomerase B
precursor [Source: RefSeq
peptide;Acc:NP_990792]
60S ribosomal protein L3 [Source:
RefSeq peptide;Acc:NP_001006241]
hydroxyacyl-coenzyme A
dehydrogenase, mitochondrial [Source:
RefSeq peptide;Acc:NP_001264826]
60S ribosomal protein L22
[Source:RefSeq
peptide;Acc:NP_989472]
60S ribosomal protein L6 [Source:
RefSeq peptide;Acc:NP_989483]
L-lactate dehydrogenase B chain
[Source: UniProtKB/SwissProt;Acc:P00337]
protein TENP [Source: RefSeq
peptide;Acc:NP_990357]
protein disulfide-isomerase precursor
[Source: RefSeq
peptide;Acc:NP_001185639]
nucleophosmin [Source: RefSeq
peptide;Acc:NP_990598]
ribosomal protein S26 [Source: HGNC
Symbol;Acc:HGNC:10414]
vinculin [Source: HGNC
Symbol;Acc:HGNC:12665]
WD repeat-containing protein 1
[Source: RefSeq
peptide;Acc:NP_001004402]
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ribosomal protein, large, P2 [Source:
HGNC Symbol;Acc:HGNC:10377]
protein SET [Source: RefSeq
peptide;Acc:NP_001025862]
ribosomal protein S25 [Source: HGNC
Symbol;Acc:HGNC:10413]
heterogeneous nuclear
ribonucleoprotein M [Source: RefSeq
peptide;Acc:NP_001026103]
60S ribosomal protein L12 [Source:
RefSeq peptide;Acc:NP_001264608]
60S ribosomal protein L31 [Source:
RefSeq peptide;Acc:NP_001264684]
acetyl-CoA acetyltransferase,
mitochondrial [Source: RefSeq
peptide;Acc:NP_001264708]
heat shock protein beta-1 [Source:
RefSeq peptide;Acc:NP_990621]
Uncharacterized protein [Source:
UniProtKB/TrEMBL;Acc:F1P304]
heterogeneous nuclear
ribonucleoprotein H [Source: RefSeq
peptide;Acc:NP_989827]
protein-glutamine gammaglutamyltransferase 2 [Source: RefSeq
peptide;Acc:NP_990779]
Uncharacterized protein [Source:
UniProtKB/TrEMBL;Acc:F1NPG6]
heterogeneous nuclear
ribonucleoprotein H3 [Source: RefSeq
peptide;Acc:NP_001012610]
caldesmon [Source: RefSeq
peptide;Acc:NP_989489]
ribosomal protein S7 [Source:HGNC
Symbol;Acc:HGNC:10440]
ATP-dependent RNA helicase DDX3X
[Source: RefSeq
peptide;Acc:NP_001025971]
lysozyme g precursor [Source: RefSeq
peptide;Acc:NP_001001470]
Uncharacterized protein [Source:
UniProtKB/TrEMBL;Acc:F1NI80]
actin-related protein 2/3 complex
subunit 4 [Source :RefSeq
peptide;Acc:NP_001244213]
Carbonic anhydrase 2 [Source:
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UniProtKB/Swiss-Prot;Acc:P07630]
guanine nucleotide-binding protein
G(I)/G(S)/G(T) subunit beta-1 [Source:
RefSeq peptide;Acc:NP_001012853]
glycerol-3-phosphate dehydrogenase 1
(soluble) [Source: HGNC
Symbol;Acc:HGNC:4455]
Gallus gallus heat shock 10kDa protein
1 (chaperonin 10) (HSPE1), nuclear
gene encoding mitochondrial protein,
mRNA. [Source: RefSeq
mRNA;Acc:NM_205067]
superoxide dismutase [Source:RefSeq
peptide;Acc:NP_990395]
60S ribosomal protein L4 [Source:
RefSeq peptide;Acc:NP_001007480]
ribosomal protein L23a [Source:HGNC
Symbol;Acc:HGNC:10317]
heterogeneous nuclear
ribonucleoprotein G [Source:RefSeq
peptide;Acc:NP_001073196]
chloride intracellular channel 4
[Source:HGNC
Symbol;Acc:HGNC:13518]
glutathione peroxidase 1
[Source:RefSeq
peptide;Acc:NP_001264782]
40S ribosomal protein S2
[Source:RefSeq
peptide;Acc:NP_001264093]
60 kDa heat shock protein,
mitochondrial
[Source:UniProtKB/SwissProt;Acc:Q5ZL72]
60S ribosomal protein L5
[Source:UniProtKB/SwissProt;Acc:P22451]
calreticulin 3 [Source:HGNC
Symbol;Acc:HGNC:20407]
capping protein (actin filament),
gelsolin-like [Source:HGNC
Symbol;Acc:HGNC:1474]
ribosomal protein S21 [Source:HGNC
Symbol;Acc:HGNC:10409]
rho GDP-dissociation inhibitor 2
[Source:RefSeq
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peptide;Acc:NP_001264293]
isocitrate dehydrogenase
[Source:RefSeq
peptide;Acc:NP_001026770]
carbonyl reductase [Source:RefSeq
peptide;Acc:NP_001025966]
Protein syndesmos
[Source:UniProtKB/SwissProt;Acc:Q9IAY5]
40S ribosomal protein S17
[Source:UniProtKB/SwissProt;Acc:P08636]
Heterogeneous nuclear
ribonucleoprotein D-like [Source:
UniProtKB/Swiss-Prot;Acc:Q5ZI72]
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Table 3: Proteins identified in bacterial database
1

Accession
gi|294828133

2

gi|517357534

3

gi|655245428

4

gi|124514345

5

gi|206742631

6

gi|292642245

7

gi|695172258

8

gi|345633807

9

gi|19705092

10 gi|124515012
11 gi|422886479
12 gi|618782811
13 gi|311693188

14 gi|297550774

Protein
histidine kinase/response
regulator hybrid protein
[Leptospira interrogans serovar
Lai str. 56601]
serine/threonine protein kinase
[Streptomyces sp. HmicA12]
protein kinase [Nocardioides sp.
J54]
Precorrin-4 C11methyltransferase
[Leptospirillum rubarum]
soluble lytic murein
transglycosylase
[Thermodesulfovibrio
yellowstonii DSM 11347]
SWIM zinc finger domain protein
[Enterococcus faecium PC4.1]
aminotransferase [Sphingomonas
taxi]
LuxR family transcriptional
regulator [Streptomyces
zinciresistens K42]
hypothetical protein FN1787
[Fusobacterium nucleatum subsp.
nucleatum ATCC 25586]
putative hydrolase, haloacid
dehalogenase-like family
[Leptospirillum rubarum]
cold shock-like protein
[Alcaligenes sp. HPC1271]
ribonucleotide-diphosphate
reductase subunit alpha
[Pseudomonas aeruginosa M10]
ATPase components of ABC
transporters with duplicated
ATPase domains [Marinobacter
adhaerens HP15]
serine/threonine protein kinase
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MW [kDa] Scores #Peptides
116.9
77.8
4
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2

72.9
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2

29.5

56.8

2

73.8

55.6

2

42.4
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2

33.6

49.5

1

24.0

48.9

1

73.8

44.1

1

24.5

43.7

1

7.5

42.3

1

107.0

38.8

1

24.5

71.7

2

73.8

65

2

15 gi|405587154
16 gi|618771208
17 gi|588290902
18 gi|114739665
19 gi|755437351
20 gi|394456251
21 gi|452006359
22 gi|618789844
23 gi|328474119
24 gi|651910070
25 gi|311694265
26 gi|546198376
27 gi|726045696
28 gi|452009578
29 gi|258592528
30 gi|516628378
31 gi|292642035
32 gi|695170760
33 gi|380733894

with TPR repeats [Ktedonobacter
racemifer DSM 44963]
transcription termination factor
Rho [Bergeyella zoohelcum CCUG
30536]
F0F1 ATP synthase subunit alpha
[Pseudomonas aeruginosa M10]
prolyl-tRNA synthetase
[Thalassolituus oleivorans R6-15]
isocitrate dehydrogenase, NADPdependent [Hyphomonas
neptunium ATCC 15444]
der GTPase activator family
protein [Yersinia kristensenii]
hypothetical protein O71_08395
[Pontibacter sp. BAB1700]
mutant NtrC-like activator
[Pseudomonas stutzeri NF13]
oxidoreductase [Pseudomonas
aeruginosa M10]
GTP-binding protein LepA [Vibrio
parahaemolyticus 10329]
hypothetical protein
[Butyrivibrio sp. AC2005]
glutathione synthase/ribosomal
protein S6 modification enzyme
[Marinobacter adhaerens HP15]
MULTISPECIES: ribosomal
protein L25, Ctc-form [Bacteria]
acetyltransferase [Candidatus
Scalindua brodae]
hypothetical protein B381_02321
[Pseudomonas stutzeri NF13]
putative Histidine kinase
[Candidatus Methylomirabilis
oxyfera]
MULTISPECIES: F0F1 ATP
synthase subunit alpha
[Bacteria][Archaea]
hypothetical protein CUO_2557
[Enterococcus faecium PC4.1]
2-keto-4-pentenoate hydratase
[Sphingomonas taxi]
serine/threonine protein kinase
[Corallococcus coralloides DSM
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55.4

61

1

63.9
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2

45.6

52.6

1

21.2

49.5

1

45.3

45.8

1

51.1

45

1

26.2

44.4

1

65.9

43.1

1

52.1

40.4

1

58.3

43.8

1

20.7

43.8

1

17.6

43.4

1

32.3

32.1

1

86.4

85.2

3

55.6

84.4

4

97.6

80.2

3

35.8

78.4

3

126.9

77

3

34 gi|292637908

35 gi|114737610
36 gi|288328957
37 gi|618792792
38 gi|300402166
39 gi|394454349
40 gi|695170101
41 gi|618777703
42 gi|291518125
43 gi|726045751
44 gi|292643035
45 gi|618771210
46 gi|691636805
47 gi|726045041
48 gi|635597237
49 gi|114740197
50 gi|667096584

2259]
NADH:ubiquinone
oxidoreductase, Na(+)translocating, A subunit
[Bacteroides xylanisolvens SD CC
2a]
putative helicase [Hyphomonas
neptunium ATCC 15444]
tetratricopeptide repeat protein
[Prevotella sp. oral taxon 317 str.
F0108]
selenocysteine synthase
[Pseudomonas aeruginosa M10]
DNA mismatch repair domain
protein [Escherichia coli MS 841]
tex-like protein [Pontibacter sp.
BAB1700]
phosphoadenosine
phosphosulfate reductase
[Sphingomonas taxi]
ATP-binding protein
[Pseudomonas aeruginosa M10]
Uncharacterized protein
conserved in bacteria
[Butyrivibrio fibrisolvens 16/4]
hypothetical protein
SCABRO_01635 [Candidatus
Scalindua brodae]
ribonuclease HIII [Enterococcus
faecium PC4.1]
F0F1 ATP synthase subunit beta
[Pseudomonas aeruginosa M10]
hypothetical protein IA69_10970
[Massilia sp. JS1662]
hypothetical protein
SCABRO_02256 [Candidatus
Scalindua brodae]
uncharacterized protein
conserved in bacteria
[Comamonadaceae bacterium B1]
putative fimbrial assembly
protein [Hyphomonas neptunium
ATCC 15444]
lytic transglycosylase
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1

15.4
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1

45.0

43.7

1

26.7

42.5

1

20.7

41

1

[Xanthomonas vasicola pv.
vasculorum NCPPB 895]
Figure 1: Functional annotation of proteins by Protein Analysis through Evolutionary
Relationships (PANTHER) a) biological process b) Molecular Functions
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Abstract
Eggshells are significant part of hatchery waste which consist of calcium carbonate crust,
membranes, and proteins and peptides of embryonic origins along with other entrapped
contaminants such as microbes. We hypothesized that using this product as a nutritional additive
in poultry diet may confer better immunity to the chickens in the paradigm of mammalian milk
that enhances immunity. Therefore, we investigated the effect of hatchery eggshell membranes
(HESM) as a short term feed supplement on growth performance and immunity of chickens
under bacterial lipopolysaccharide (LPS) challenged condition. Three studies were conducted to
find the effect of HESM supplement on post hatch chickens. In the first study, the chickens were
fed either a control diet or diets containing 0.5% whey protein or HESM as supplement and
evaluated at 5 weeks of age using growth, hematology, clinical chemistry, plasma
immunoglobulins, and corticosterone as variables. The second and third studies were done to
compare the effects of LPS on control and HESM fed birds at 5 weeks of age where the HESM
was also treated with ethanol to inactivate bacterial factors, and the effects of LPS evaluated at 4
and 24 h of treatment. HESM supplement caused a numerical but nonsignificant weight gain in 2
experiments and consistently decreased the blood corticosterone levels. LPS caused a significant
loss in body weight at 24 h following its administration but the HESM supplemented birds
showed significantly less body weight loss compared with the control fed birds. The WBC,
heterophil/lymphocyte ratio, and the levels of IgG were low in chickens fed HESM supplement
diet compared with the control fed group. LPS challenge increased the expression of proinflammatory cytokine gene IL-6 but the HESM fed birds showed its effect curtailed also,
favored the up-regulation of some anti-inflammatory genes compared with control fed chickens.
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Post hatch supplementation of HESM appears to modulate immunity, and increase their
resistance to endotoxin.

Key words: Hatchery eggshell membrane, chicken, lipopolysaccharide, gene expression,
corticosterone
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Introduction
Eggshells which constitute a significant part of hatchery waste consist of calcareous crust, shell
membranes, proteins and peptides of embryonic origins, and entrapped contaminants including
microbes [1, 2]. Proteomic analysis of the eggshell membranes (ESM) have shown the presence
of over 200 proteins and peptides belonging to structural, antimicrobial, and cell-regulatory
genre [3-5] with the hatchery eggshell membrane (HESM) enriched with many blood derived
proteins (Makkar et al., in preparation). We hypothesized that HESM as a feed supplement may
be beneficial to post hatch poultry in the paradigm of mammalian milk, which contain many
similar proteins and peptides such as lactoferrin, lysozyme, albumin, and other factors that help
gastrointestinal development and help development of immunity in neonates [6, 7]. However,
the functional stability of these proteins to harsh processes such as, drying, decontamination, and
passage through the gastrointestinal tract is not known. Reports in the literature have shown the
biological effects of different enzymes, antibodies, recombinant cytokines, and other bioactive
protein additives in animal feed [8-13]. Previously, we showed that nutritional supplement of
eggshell membrane (ESM) from fresh unfertilized eggs given to the chickens during first 2
weeks post hatch, improved growth, increased serum immunoglobulins, and reduced several
stress variables such as plasma corticosterone, heterophils, and heterophil/lymphocyte ratios[14].
The growth supportive effects of fetal proteins have also been demonstrated in other
experimental models [15, 16], The muco-adhesive membrane particles may also act as carriers of
microbial antigens along with other adjuvant-like proteins and peptides [17, 18] that help to
develop resistance or tolerance to pathogens. Hence, the objective of this research was to explore
the effect of HESM supplements on the performance of post hatch chickens stressed with
endotoxin during the grow-out period.
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Materials and Method
Preparation of HESM and its sterilization
Empty eggshells collected from a hatchery were dried at room temperature and the membranes
separated from the shells and pulverized to powders and flakes with an IKA mill (Cole Parmer).
The protein nitrogen content of the membrane powder before and after mixing with feed were
estimated by Duma’s nitrogen analyzer using duplicate samples [14]. Three feeding experiments
were conducted: study 1 utilized intact HESM while the studies 2 and 3 utilized HESM flakes
sterilized with ethanol to reduce bacterial and endotoxin contaminants. In studies with ethanol
sterilization, the HESM flakes were treated with 3 volumes (w/v) of reagent grade ethanol,
enough to wet the flakes, and then air dried in a chemical hood without decantation. The effect
of this treatment was evaluated using bacterial colony count assays [19] and the production of
nitrite by HTC macrophages due to endotoxin [20]. Briefly, duplicate samples of untreated and
ethanol treated HESM powders were extracted with sterile saline at the concentrations of 100
mg/ mL at room temperature for 2 h and centrifuged at 21,000 g. Respective supernatants were
serially diluted and 100 µl of each sample was plated on agar plates in triplicate, and incubated
for 24 h at 37oC to evaluate for bacterial growth. The same extracts were also evaluated for
endotoxin activities using nitrite production by the HTC chicken macrophages following 24 h of
stimulation and compared with Salmonella LPS (1µg/ml) used as a positive control [20].
Experimental Schedule
The animal study protocols were approved by the Institutional Animal Care and Use Committee
(IACUC) of the University of Arkansas. Newly hatched Cobb 500 male chicks were raised on
floor pens at a density of 8 square feet /bird with 23:1 light: dark schedule and provided feed
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formulated per National Research Council [21] specification and ad libitum water. The HESM
was added at 0.5% level to broiler starter diet based on previous experiments. In Study 1 the
effects of crude HESM and a comparable level of whey protein powder were tested on the
growth performance and general physiological parameters of 5-wk-old chickens as described
later. In Studies 2 and 3, the HESM powder was ethanol sterilized and used as the feed
supplement where the effects of Salmonella typhimurium lipopolysaccharide was evaluated
following 24 or 4 h of treatment. In all the experiments, the chickens were fed diets containing
the supplement for 14 days post hatch then switched to un supplemented diet for the rest of the
time until necropsy. The birds were monitored daily for mortality, welfare and evaluated weekly
for body weight (BW), and feed consumption. The BW of the birds were measured before LPS
injection and prior to necropsy when necessary.
In Study 1, 72 one day-old chicks were divided into 3 groups each with 24 birds in two replicate
pens. The three groups received diets as follows: 1) control feed with no supplement, 2) feed
containing 0.5% whey protein powder as a secondary control to find whether the effect was due
to protein supplement alone, and 3) feed containing 0.5% HESM. Prior to necropsy, 6 birds
from each pen (12/group) were bled by cardiac puncture, blood collected using EDTA containing
Vacutainer as well as rapid serum tubes (BD Falcon) for hematology and clinical chemistry
assays respectively [14].
Studies 2 and 3 were done with ethanol sterilized HESM. Growth performance of the birds
along with differnt physiological changes including the effects of Salmonella typhimurium LPS
(cat # HC4060 Sigma-Aldrich, St. Louis, MO) were determined. In Study 2, the day-old
chickens were allocated into 2 groups and given feed with or without 0.5% HESM as described
above then switched to regular feed through 5 weeks of age. On day 34, 12 birds in each group
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were injected intramuscularly in the thigh with LPS at the concentration of 1 mg/kg BW in saline
and the rest received equal volumes of saline. The effect of LPS was monitored visually for 5 h
following injection with the BW measured before and after 24 h of injection. Prior to necropsy,
12 chickens/group were bled for hematology and clinical chemistry assays. At necropsy, the
weights of selective organs from all the birds were recorded.
In Study 3, the effect of LPS on splenic expression of selective genes associated with different
immune function were determined. Chickens from control and HESM groups received either
saline or LPS injection as described earlier. Four h after the injection 6 chickens from each
group were killed and the spleens placed in liquid nitrogen for RNA extraction, and the rest
killed after 24 h to record BW and organ weights.
Necropsy
The liver, heart, spleen, and bursa weights from all birds were used to calculate the percentage
relative to BW. In Study 2, a cm length of ileum below the pancreatic loop was excised from
each of six control and HESM fed birds and fixed in Carnoy’s fluid for ~5 h, transferred to 70%
alcohol then processed for histology. Six micron paraffin sections were stained with periodic
acid Schiff (PAS) hematoxylin staining and examined for villus health, mucous secretion, and
gross abnormality by visual observation. The sections were photographed in BX Olympus
microscope.

Hematology
Blood cell counts along with hemoglobin content, mean corpuscular volume (MCV), hematocrit,
microhematocrit (MCH), red blood cell distribution width (RDW) values were measured using
EDTA anticoagulated blood by the use of Cell-Dyn 3500 blood analysis system (Abbott
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Diagnostics, Abbott Park, IL) standardized for avian blood and the heterophil to lymphocyte
ratios (H/L) calculated.

Serum assays
The serum metabolic parameters were assayed using a clinical chemistry analyzer (Ciba Corning
Diagnostics Corp, Medfield, MA). Corticosterone concentrations were measured by Detect X
enzyme immunoassay kitTM (Arbor Assays, Ann Arbor, MI) using predetermined dilutions of
sera [14]. The IgM, IgG, and IgA concentrations were similarly, determined using respective
assay kits from Bethyl Laboratory (Montgomery, TX) with the serum diluted to 1:1000 with the
manufacturer supplied buffer for IgA, 1:50,000 for IgG, and 1:20,000 for IgM, respectively. The
concentrations of antibodies in the sera were calculated from their respective standard curves.
Gene expression
The expressions of inflammation regulatory genes such as pro-inflammatory (IL-1β, IL-6, IFNγ), anti-inflammatory (IL-4, IL-10, IL-12), and immunosuppressive, wound repair supportive
factors (TGF-β3 and vascular endothelial growth factor (VEGF) [22-24] were determined using
splenic tissue RNA and quantitative RT-PCR. Six frozen spleens from each treatment group
were split into 4 quarters and ~ 100 mg of tissues from equivalent region of each spleen were
extracted with Tri Reagent (Sigma-Aldrich) to prepare RNA. Complementary DNA (cDNA) was
synthesized using 1 µg of RNA and qScript™ cDNA SuperMix (Quanta biosciences) following
manufacturer's protocol. Quantitative real-time PCR was performed using SYBR® Green PCR
Master mix (Life technologies) in an ABI 7500 Real-Time PCR system (Applied Biosystems,
Carlsbad, CA). A 25 µl reaction containing 5 µl cDNA (1 µg of RNA equivalent) and primers
specific against chicken IL-1β, IL-4, IL-6, IL-10, IFN-γ, TGF-β3, VEGF and IL-12
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(Supplementary Table 1) were subjected to PCR with initial denaturation at 95°C for 10 minutes
followed by 40 PCR cycles as follows: 95 °C for 15 s, 58 °C for 1 min. Expression of target
genes were analyzed by the 2−ΔΔCt method [25] with 18S RNA used as reference gene.

Statistical analyses
All results were evaluated using Duncan's t test using SAS software [26] and a P-value of <0.05
considered to be significant.The results are shown as mean±SEM.
Results
HESM
The average protein content of HESM was determined to be approximately 88% (w/w) the
addition of which did not significantly alter the protein content of feed (Control: 25.1% and
HESM: 25.3%, n=2 samples/group). The number of bacterial colonies showed a significant
reduction from 30,000 / ml in untreated HESM extract to less than 5 colonies in ethanol treated
HESM. Similarly, the ethanol treatment reduced the endotoxin content of HESM judged by a
significantly low level of nitrite production by the HTC cells (Figure. 1)
Effect on BW, mortality
In Study 1, there were no significant differences in body weight (BW) or relative organ weights
of the birds given HESM supplemented feed compared with either control or whey protein
supplemented groups (Supplementary Table 2). In both Studies 2 and 3, the birds fed HESM
supplement diet showed a slight but statistically nonsignificant increase in BW and no
differences in relative organ weights compared with control group. Cumulative mortality rate in
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all 3 experiments combined, showed no differences between control and HESM fed chicks
(Table 1).
LPS effect
LPS treated chickens showed symptoms of sickness indicated by lack of activity, eyelid closure,
and feed avoidance within 3 h of treatment and decreases in BW by 24 h. The relative liver
weights were significantly increased and bursa weights decreased in LPS treated groups although
this effect was not seen with heart and spleen. The chickens that received HESM showed
comparatively less (p≤ 0.05) BW loss relative to control fed birds (Table 1, Figure. 2).
Hematology and serum chemistry
The results from Study 2 and the effect of LPS are shown in Table 2. HESM treatment per se
had no effect on lymphocyte (L), monocyte (M), heterophil (H), or basophil (B) percentages, and
H/L ratios. On LPS treatment, there was an increase in percentages of heterophil, monocyte, and
basophils, and H/L ratios, and a reduction in lymphocyte counts in both groups. The relative
decrease in heterophil and increase in the lymphocyte counts resulted in a significant decrease of
H/L ratios in HESM group compared with controls and challenged with LPS (Table 2). There
were few other changes including increased hematocrit in HESM birds and treated with LPS.
HESM produced a moderate decrease in serum protein, calcium, and magnesium levels some of
which increased upon LPS treatment. LPS caused a decrease in serum iron and increase in
triglycerides in both groups (Table 3). The cholesterol and HDL levels were down regulated in
serum of control birds as compared to HESM when challenged with LPS. Neither alanine nor
the aspartate amino transferases were affected by HESM indicating the lack of liver toxicity.
Serum immunoglobulins and corticosterone
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In Study 1 there was no changes in serum IgM levels of chickens fed whey protein or intact
HESM but the IgG levels decreased with HESM (Supplementary Table 3). Similar trend was
observed in the 2nd study that upon LPS treatment increased the serum IgM while the IgG level
remained unchanged in HESM fed birds. Neither treatment had any effect on serum IgA (Table
4). The corticosterone was consistently lower in both studies in HESM fed birds but with LPS
treatment, it increased moderately reaching to the same levels as control birds (Table 4).

Gene expression
The splenic gene expression results are shown in Table 5. Chickens fed regular diet and
challenged with LPS had a significant increase in IL-6 gene expression compared with HESM
fed group (Figure 3). The anti-inflammatory gene IL-10 showed a significant increase in the
HESM group when challenged with LPS (Figure 4). The IL-4 gene was downregulated in
HESM birds but on LPS treatment its expression was significantly higher compared with control
fed chickens (Figure 5). There was no change in the expressions of IFN-g or IL-12. But the TGFβ expression showed a significant decrease by LPS treatment in both control and HESM fed
groups whereas the VEGF downregulated in HESM birds regardless of LPS treatment.

Histology
There were no differences in the overall health of intestine between the control and HESM diet
fed birds judged by villus morphology, muscularis, and mucus deposition (Supplementary Figure
1).
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Discussion
Our results show that feeding HESM is beneficial to chickens particularly in decreasing stress
levels and improving resistance to LPS-induced changes. These results are consistent with our
previous report where the egg shell membranes (ESM) from fresh unfertilized eggs improved the
performance of 3 week old chickens with respect to body weight and downregulated
corticosterone and other stress parameters[14]. In the previous study with ESM we observed an
increase in the levels of IgG and IgM at 3 weeks but in the present study the IgM levels appeared
not to be affected which may be due to later sampling time of 5 weeks when the early response
to antigens tend to subside [27-29]. However, the cause of IgG downregulation in HESM fed
birds is not understood.
Weight loss is a hallmark of endotoxemia in both mammals and birds which is mediated
through several pro inflammatory cytokines such as IL-1, IL-6, and TNF-α [30-33]. These
cytokines not only cause hypophagia but also promote protein catabolism [34]. The HESM
appears to curb the effect of endotoxin promoting weight loss also modifies the splenic
expression of cytokine genes that are associated with inflammation [35-39]. Similarly, there was
a persistent downregulation of corticosterone and other stress markers such as heterophil to
lymphocyte ratios [40] in HESM fed birds that could account for their better performance.
Glucocorticoids can not only be anti-anabolic but also immunosuppressive [41]. Lower stress
can improve feeding and decrease susceptibility to pathogens in poultry [42]. However, the
mechanism by which the ESM lower the stress parameters is not understood since the effect
appears to persist beyond the period of discontinuation of feeding HESM. Hypothetically a
decreased serum level of adrenal steroids can be expected upon endocrine exhaustion occurring
under conditions such as chronic endotoxemia. However, it is not the case in this study because
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the HESM was not only deplete of endotoxin but also, the chickens fed on it showed any sign of
sickness judged from their BW, intestinal pathology and blood profiles.

Although the expression of IL-6, was upregulated by LPS treatment in both feed groups, it was
significantly low in birds fed HESM. Similarly, there were also the upregulation of IL-4 and IL10, both of which are considered as anti-inflammatory cytokines implicated in the development
of immune tolerance [43, 44]. Anti-inflammatory effect of natural ESM has been reported in
experimental models of joint inflammation where the effects were attributed to the proteoglycan
content of the preparation [45, 46]. Similar findings were reported by Shi et.al in mice where the
effect of hydrolysate of eggshell membrane provided protection against dextran sodium sulfate
induced intestinal inflammation [47]. The TGF-β expression was lower in both feed groups
injected with LPS while the VEGF showed consistently lower expression in HESM birds. Since
these growth factors help tissue repair and angiogenesis, associated with the resolution of
inflammation, [23] their downregulation during early phases of inflammation is likely. However,
the decrease in VEGF expression in birds fed HESM treatment is not understood. Whether the
patterns of expressions of pro and anti-inflammatory cytokines have any relevance in curbing the
body weight loss in HESM fed chickens is not known. Evidently, a modified immune response
due to HESM confers resistance to endotoxin induced changes. As the susceptibility to infection
can increase in immunocompromised individual likewise, it may confer tolerance to disease in
immune strengthened birds.

There were no significant differences in IgM or IgA levels of chickens fed either control or
HESM diet with or without LPS challenge. By contrast, the IgG levels were reduced in birds fed
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HESM that did not substantially change even after LPS treatment. Hypogammaglobinemia with
normal IgM and IgA have been noted in human patients with physical trauma such as burn and
nephrosis [48]. But the chickens fed HESM had neither physical trauma nor their clinical
chemistry showed any indication of dysregulated kidney function such as hypoalbumenemia and
hyperlipidemia that can be associated with nephrotic conditions. The HESM induced down
regulation of serum corticosterone is consistent with our previous results with ESM [14]. We
presume that post hatch exposure to HESM which is laden with different regulatory proteins and
peptides and the remnants of bacterial and parasite contaminants possibly, condition the neuroimmune system lowering the disposition of birds to stress and higher tolerance to LPS. In newly
hatched birds as in mammalian neonates, the immune and neuroendocrine system is immature
and prone to epigenetic conditioning. At this stage not only the maternal but also other
biodiverse factors such as diets, and microbes provide signals that can shape immunity and
establish tolerance and resistance to pathogens [49-52]. There is increasing evidence showing
that the neonatal exposure to stress, diets and microbiome have long term effect on immunity,
health, and wellbeing of individuals [53, 54]. Besides, the enteric system houses the second
largest density of neurons that could be impacted by bioactive factors thereby can influence
immunity; for example, it is now known that the immune functions of lymphoid organs such as
spleen can be prone to control through neural output of autonomic system and T cell regulation is
subject to cholinergic output [55, 56]. Thus, the bioactive embryonic factors in HESM
modulating the immune response of chickens is a possibility. Also, it is now well recognized
that maternal factors such as milk along with exposure to microbiome are important factors for
establishing disease resistance and post-natal conditioning in mammals [57]. The plethora of
proteins and peptides present in the eggshell membrane could simulate those effects in chickens.
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From the foregoing discussion it is clear that HESM supplementation of feed is beneficial to post
hatch poultry and it curtails the harming effects of LPS. Whether the effects are due to the
bioactive proteins and peptides or some other factors is not known. Very little is known as to
whether and how food associated bioactive proteins influence immunity because most
omnivorous birds and mammals rely on some sort of raw proteins and peptides for their early
nutrition which could provide epigenetic conditioning of immune system and build their
resistance against common infections. The postnatal immune system being immature but plastic
it certainly provides opportunity for nutritional modulation for building better immunity [58] In
conclusion, our results show that HESM supplement can be a sustainable feed additive to
improve immunity and health physiology of poultry.
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Table 1. Body weight (BW) and the relative organ weights (% BW) of 5-week-old chicken fed
diets with sterilized HESM and challenged with LPS for 24 h: Studies 2 and 3 combined
(n=32-36).
Saline
Parameters
BW (g)

Control
2238.27±33.38a

LPS
HESM
2327.23±40.77a

Control

HESM

2021.30±37.02c

2135.38±28.55b

Heart

0.52±0.01a

0.51±0.01a

0.52±0.01a

0.52±0.01a

Liver

2.63±0.04b

2.48±0.06b

3.41±0.08a

3.30±0.09a

Spleen

0.12±0.01a

0.12±0.00 a

0.13±0.01a

0.13±0.01a

9±1.53a

14.33±3.48a

-

-

Mortality (%)*

Values with different superscripts in a row are significantly different (P<0.05). *Results based
on 3 experiments
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Table 2.Hematology profiles of chickens fed with or without HESM containing feed and treated
with LPS: Study 2 (n=12)
LPS

Saline
Parameters

Saline
Control

3

WBC (10 /µL)

49.76±1.42

Heterophil (H) (%)

HESM
a

Control

HESM
a

45.60±3.0b

46.01±1.75 b

54.09± 3.12

11.44±0.36c

12.62±0.46c

30.85±2.35a

22.94±3.14b

Lymphocytes (L) (%) 83.81±0.65a

82.31±0.70a

61.80±2.22c

69.92±3.10b

(H/L)

0.14±0.01c

0.15±0.01c

0.50±0.06a

0.32±0.05b

Monocytes (M) (%)

2.32±0.18 b

2.75±0.28b

4.31±0.33a

4.01±0.26a

Eosinophil (E) (%)

0.02±0.01a

0.01±0.00 a

0.02±0.00 a

0.02±0.00a

Basophil (B) (%)

1.99±0.17b

2.3±0.18b

2.99±0.19a

3.03±0.17a

Red blood cell (×
106/µL)

2.18±0.04a

2.18±0.04a

2.24±0.03a

2.33±0.02a

Hemoglobin (g/dL)

6.77±0.09b

6.80±0.085b

6.92±0.062b

7.17±0.073a

Hematocrit (%)

59.26 ±1.15b

60.27±0.98b

60.11±0.68b

63.02±0.65a

Mean corpuscular
volume (MCV)(fL)

271.23±1.73b

276.16±1.69a

267.32±1.58b

271.07±1.16b

Thrombocyte (k/µL)

0.03±0.03a

0.00±0.00a

0.64±0.44a

0.003±0.00 a

Values with different superscripts in a row are significantly different (P ≤ 0.05).
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Table 3.. Serum clinical chemistry variables of 5 week-old chickens fed with regular diet or the
diet supplemented with 0.5% HESM and challenged with LPS: Study 2 (n=12).
Saline
Parameters

Control

LPS
HESM

Control

HESM

Albumin (g/dL)

1.15± 0.02a,b

1.08± 0.02 b

1.17± 0.02a

1.19± 0.03a

Glucose(mg/dL)

213.15±4.18a

216.15± 3.64 a

199.08± 4.14b

212.85± 5.63a

Inorganic
phosphate
(mg/dL)

3.31±0.16b

3.28± 0.13b

3.28± 0.17b

4.01± 0.21a

Total
protein(g/dL)

3.12± 0.06a

2.76± 0.04b

3.15 ± 0.05a

3.22± 0.01a

Alkaline
phosphate (U/L)

193.77± 24.24a,b

226.31± 28.60a

139.77 ± 14.90b

192.85±24.93a,b

Alanine
aminotransferase
(U/L)

3.85 ± 0.62a

2.49± 0.49a

2.75± 0.44a

3.85± 0.56a

Aspartate
Aminotransferas
e (U/L)

309.45±17.4a

348.67±29.45 a

324.95±18.49a

380.83±24.72a

Blood urea
nitrogen (mg/µL)

1.61± 0.13a

1.05± 0.15 a

1.33± 0.08 a

1.30± 0.08a

Magnesium
(mEq/L)

1.90± 0.05a

1.58± 0.04 b

1.73± 0.05 a ,b

Calcium (mg/dL)

10.53± 0.23a

7.99± 0.26 c

10.28± 0.29a
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1.68± 0.11b

9.40± 0.27 b

Cholesterol
(mg/dL)

165.15± 6.91a

166.00± 4.16a

138.54±4.05b

161.31 ± 6.20a

Creatinine
kinase(U/L)

546.8±83.43a,b

821.9 ± 166.59a

288.9± 36.06b

388.7± 46.39b

Triglycerides
(mg/dL)

55.00± 4.86 b

51.07± 3.28b

93.00± 5.49a

86.31± 6.93a

High density
lipoprotein
(mg/dL)

45.15± 2.81a

44.77± 1.28 a

35.69± 1.24 b

41.23± 1.61a

Iron (µg/dL)

99.54± 4.94 a

93.85± 4.80 a

55.46± 5.18 b

57.77± 9.27 b

Values with different superscripts in a row are significantly different (P ≤ 0.05).
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Table 4.. Serum IgG, IgM, IgA, and corticosterone levels of chickens fed regular NRC diet or
diets supplemented with ethanol sterilized HESM and challenged with LPS for 24 h.: Study 1
(n=12)
Saline

LPS

Parameters

Control

IgM (mg/ml)

2.84±0.30b.a

1.93±0.24b

3.83±0.40a

3.50±0.47a

IgG (mg/ml)

4.78±0.68a

1.23±0.17b

3.53±0.53a

0.98±0.17b

IgA (mg/ml)

0.56±0.15a

0.54±0.22a

1.18±0.17a

0.81±0.39a

Corticosterone

7.74±0.95a

5.01±0.53b

6.7±0.60a,b

6.58± 0.96a,b

HESM

Control

Values with different superscripts in a row are significantly different (P ≤ 0.05).
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HESM

Table 5. Study 3. The expression of splenic genes quantified by RT-PCR in birds fed with and
without HESM and injected with LPS or saline (n=6)
Saline
Parameters

LPS

Control

HESM

Control

HESM

IL-1

1.00± 0.24b,a

0.75±0.11b

1.32±0.25b,a

1.83±0.61a

IL-6

1.00±0.24b

1.08±0.17b

3.52±0.37a

2.42±0.49b

IL-10

1.00± 0.10b,c

0.89±0.19c

2.3±0.34b

4.26±0.95a

IFN-γ

1.00±0.28a

0.99±0.26a

0.68±0.13a

1.15±0.31a

TGF-β

1.00±0.20a

0.97±0.14a

0.28±0.04b

0.30±0.04b

IL-12

1.00±0.13a

1.43±0.32a

1.13±0.26a

1.64±0.19a

VEGF

1.00±0.13a

0.32±0.08 b

0.86±0.11 a

0.31±0.04b

IL-4

1.00±0.13b,c

0.67±0.12c

1.76±0.32b

2.82±0.68a

Values with different superscripts in a row are significantly different (P<0.05).
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Figure legends
Figure 1. Nitrite production at 24 h by the HTC chicken macrophage in response to different
treatments.
Figure 2. Effect of HESM on body weight of 5 week old birds, challenged with LPS for 24h
n=(32-26). Values with different superscripts are significantly different.
Figure 3. Comparison of splenic IL-6 gene expression in chickens fed control and HESM diet
and challenged with LPS or Saline for 4 h (n=6). Values with different superscripts are
significantly different (p≤0.05).
Figure 4. Splenic IL-10 gene expression comparison of chickens fed control or HESM
supplemented diet and treated with LPS or Saline for 4 h (n=6). Values with different
superscripts are significantly different (p≤0.05).
Figure 5 Comparison of splenic IL-4 gene expression in chickens fed control and HESM diet and
challenged with LPS or Saline for 4 h (n=6). Values with different superscripts are significantly
different (p≤0.05).
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Figure 3
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Supplementary Table 1. PCR primers and accession numbers of candidate genes for
chicken cytokine and other proteins
Target
genes

Accession
number

IL-1β

NM_204524.1

Primer sequences

SF：CGAGGAGCAGGGACTTTGC

Length of
product (bp)
71

SR：GAAGGTGACGGGCTCAAAAA
IL-6

NM_204628.1

SF：GCTTCGACGAGGAGAAATGC

63

SR:GGTAGGTCTGAAAGGCGAACAG
IL-10

NM_001004414.2

SF：CGCTGTCACCGCTTCTTCA

63

SR：CGTCTCCTTGATCTGCTTGATG
IFN-γ

NM_205149

SF：AAAGCCGCACATCAAACACA

64

SR：GCCATCAGGAAGGTTGTTTTTC
TGF-β3

NM_205454.1

SF：TGCGGCCAGATGAGCAT

55

SR：TGCACATTCCTGCCACTGA
18S rRNA

NC_006088.3

SF：TCCCCTCCCGTTACTTGGAT

60

SR：GCGCTCGTCGGCATGTA
IL-12

NC-46430425

SF:TGCCCAGTGCCAGAAGGA

57

SR:TCAGTCGGCTGGTGCTCTT
VEGF-A

GI 160358852

SF:AAATTCACAGACTCACGTTGCAA

61

SR: ATCTGCAAGTGCGCTCGTTT
IL-4

NM_0010079.1

SF: GCTCTCAGTGCCGCTGATG
SR: GAAACCTCTCCCTGGATGTCAT
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Supplementary Table 2. Study 1. Body weight (BW) and the relative organ weights (% BW) of
5 week-old chicken fed diets containing 0.5% whey protein powder or 0.5% HESM (n=2023).
Parameters

Control

0.5% whey
protein

0.5% HESM

BW (g)

2153.95±45.97a

2219.65±37.20a

2148.00±37.74a

Heart

0.56±0.02a

0.53±0.02a

0.57±0.02a

Liver

2.20±0.04a

2.18±0.05a

2.3±0.06a

Spleen

0.11±0.01a

0.12±0.01a

0.11±0.01a

Bursa (%)

0.15±0.01 a

0.16±0.02a

0.16±0.01a

Values with different superscripts in a row are significantly different (P<0.05).
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Supplementary Table 3. Study 1. Comparison of serum IgG, IgM, and corticosterone levels of
chickens fed with regular NRC diet or 0.5% whey protein, or HESM supplemented diet. The
results are shown as mean ± SEM. (n=12/ group)
Parameters

Control

0.5% whey
protein

0.5% HESM

IgG (mg/mL)

1.20±0.07a

1.07±0.06a

0.82±0.07b

IgM (mg/mL)

2.69±0.24a

2.54±0.30a

2.60±0.22a

Corticosterone
(ng/mL)

5.75±0.77a

4.26±0.33a,b

3.81±0.41b,c

Values with different superscripts in a row are significantly different (P ≤ 0.05).
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Supplementary Figure 1. Histology of intestine sections of control and HESM fed birds
(magnification X400)

Control

HESM
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VI. CONCLUSION
The immune system of a newly hatched chick is functionally immature and plastic. It can be
primed and modulated by numerous ways, which can make it more resilient to fight infections in
later life. Pre and postnatal life is critical time for the immune system for epigenetic
programming for development of resistance and tolerance and the nutritional modulation can be
a major option to this end. In mammals for example, the mother’s milk that contains a plethora
of defense proteins, peptides, and growth factors provide such programming boosting resistance
against microbes, provide probiotic factors for microbiome, and anti-infective benefits to the
immature gut. The diets in birds living in wild may consist of fresh worms, insects, fish or food
which can provide such programming which the domesticated poultry raised under controlled
conditions may not have that exposure. Using eggshell membrane matrix and following its
composition and biological effects our data suggest that the factors associated with this
physiological modulation that provides protection of chicks against LPS induced changes.

Using ESM from both fresh unfertilized as well as from hatchery egg membranes, we found that
it contain more than 270 proteins, which are not only antimicrobial in nature, but they are also
associated with cell signaling, development process, and immune system regulation processes
(chapter2/4) largely of embryonic and hematological origins. The rejuvenation potential of body
fluid factors of young animals was shown using parabiotic mice ( ) suggesting that these factors
can influence physiology. In extrapolating the concept we think that ESM factors which contain
many antimicrobial, cell organizing, and cell signaling proteins perhaps produce the effects
through neuroendocrine immune organizational pathways (chapters 3 and 5).
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These experiments can be foundational to explore the idea that post hatch modulation of
physiology and immunity using allogeneic or xenogeneic bioactive factors and microbes may
confer life time resistance and tolerance to poultry against pathogens.
With respect to ESM, this byproduct can be reusable and saleable without causing any
biosecurity issues. This research would help for utilization of hatchery waste eggshell
membranes in a potentially valuable and profitable manner.

166

